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ABSTRACT OF DISSERTATION 
THERAPEUTIC VIDEO GAMES 
AND THE SIMULATION OF EXECUTIVE FUNCTION DEFICITS IN ADHD 
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental 
disorder characterized by difficulty paying attention, impulsivity, and hyperactivity. 
Diagnosis of ADHD rose 42% from 2003–2004 to 2011–2012. In 2011, 3.5 million 
children were treated with drugs.  Optimizing therapy can take a year, and may not be 
completely effective.  
A clinical trial is currently being conducted of a device/drug combination using the 
computer game Minecraft, to determine how certain activities affect executive function, 
working memory, and restraint in patients diagnosed with ADHD.  The human subjects’ 
responses are being modeled using artificial neural networks (ANNs), an artificial 
intelligence method that can be utilized to interpret highly complex data. We propose using 
ANNs to optimize drug and Minecraft therapy for individual patients based on the initial 
NICHQ Vanderbilt assessment scores. We are applying ANNs in the development of 
computational models for executive function deficiencies in ADHD. These models will 
then be used to develop a therapeutic video game as a drug/device combination with 
stimulants for the treatment of ADHD symptoms in Fragile X Syndrome. 
As a first step towards the design of virtual subjects with executive function 
deficits, computational models of the core executive functions working memory and fluid 
intelligence were constructed. These models were combined to create healthy control and 
executive function-deficient virtual subjects, who performed a Time Management task 
simulation that required the use of their executive functions to complete. The preliminary 
working memory model utilized a convolutional neural network to identify handwritten 
digits from the MNIST dataset, and the fluid intelligence model utilized a basic recurrent 
neural network to produce sequences of integers in the range 1-9 that can be multiplied 
together to produce the number 12. A simplified Impulsivity function was also included in 
the virtual subject as a first step towards the future inclusion of the core executive function 
inhibition. 
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neural networks 
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CHAPTER 1. BACKGROUND 
1.1 Executive Functions 
Executive functions are a set of effortful, top-down mental processes that govern 
attention and regulate behavior1. Executive functions enable both visualization of the future 
and remembrance of the past, allowing for control of one’s behavior over time to 
accomplish long-term goals and self-reflection to recognize past mistakes so that they are 
not repeated. In addition to the consideration of behavior across time, executive functions 
also enable conscious manipulation of thoughts and ideas, which includes the use of 
creativity to combine conflicting ideas in novel ways.  
A set of core executive functions has been proposed to serve as a foundation for 
higher order executive functions and the general application of executive functioning in 
life activities1. These core executive functions include working memory, inhibitory control, 
and cognitive flexibility. Fluid intelligence is a higher order executive function that 
requires the use of the core executive functions for its execution. Application of the 
executive functions allows for the development and use of important skills such as time 
management, organization, planning, self-regulation, sustained attention, and 
metacognition. 
Working memory and inhibition are described as distinct core executive functions, 
but work together very closely1. Working memory is the ability to hold a piece of 
information in consciousness (short-term memory) and then manipulate it in some way2. 
Inhibitory control includes the ability to ignore environmental distractions (attentional 
control3 as well as the ability to prevent automatic or impulsive thoughts and behaviors 
when they may not be appropriate. The inhibitory control of automatic thoughts, 
particularly thoughts resulting from previous experiences that may interfere with 
appropriate responses to present circumstances4 is of interest in this project. When working 
memory is active, attention focuses on the information present in short-term memory, 
which precludes the capture of this attention by unproductive thoughts and supports their 
inhibition. Likewise, when inhibition is actively preventing the intrusion of distracting 
thoughts, a greater degree of attention remains free for the use of working memory. 
Cognitive flexibility5 includes the ability to change perspectives and adjust 
accordingly when situational changes arise, and may be conceptualized as the combined 
use of working memory and inhibition1. For example, when one attempts to change 
perspectives the old perspective may continue to intrude as the individual effortfully 
focuses their attention on the consideration of the new perspective. Thus, cognitive 
flexibility in this case requires the use of inhibition to prevent the focus of attention on the 
old perspective while the use of working memory shifts these attentional resources towards 
the consideration of a new perspective. 
Fluid intelligence is the use of adaptive reasoning in novel situations6. For the 
purposes of this project fluid intelligence is considered as a problem solving ability 
consisting of the mental processes analysis and synthesis7. Analysis is the deconstruction 
of a complex idea into simpler pieces, whereas synthesis is the combining of simpler ideas 
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in various ways to construct larger, complex ideas. A pertinent example of the use of fluid 
intelligence is in the practice of time management. When considering how to complete a 
complex task most efficiently, one may first analyze the task carefully to determine the 
individual steps needed for its completion. There will be a finite number of ways to 
organize these steps, and the best sequence of steps will be the one that produces the best 
outcome in the shortest amount of time. Working memory and the synthesis process of 
fluid intelligence can be used to mentally rehearse the completion of varying combinations 
of these steps and determine the time required to complete them. Some combinations of 
steps may overlap better in time than others when they are completed sequentially, and 
some steps may be found to provide minimal contributions to the overall goal. The order 
of the overlapping steps may then be preserved in the final sequence, and the marginally 
important steps may be left at the end of the sequence to be completed after the more highly 
prioritized steps should time permit. In this way, fluid intelligence can work together with 
the core executive function working memory in a time management activity. 
As will be explained in detail later, a central component of this project is the 
construction of computational models that simulate the use of executive functions in virtual 
tasks designed to resemble real-life activities that train executive functions. In the initial 
computational model described here, simplified representations of working memory and 
the synthesis component of fluid intelligence were combined to create a virtual time 
management activity. In lieu of behaviors being chosen and combined to complete a goal 
in the most efficient manner as described above, integers between 1 and 10 were chosen 
and combined to produce the larger integer 12. Working memory is represented here by 
the identification of integers that are contained in image files of handwritten digits in the 
MNIST dataset8. As a first step towards building a representation of inhibitory control, an 
impulsivity function that interferes with the use of the working memory handwritten digit 
identification function is included. Finally, the synthesis process of fluid intelligence is 
represented by the combining of integers into sequences to produce the number 12.  
The construction of a set of virtual executive function activities that represent real-
life executive function training activities in human subjects could enable the rapid 
computational simulation of different schedules of these activities. If a virtual set of 
activities can be designed to resemble the use of human executive functions closely 
enough, the simulations could potentially provide insight into how variations in the 
selection and scheduling of these activities affect the outcomes of executive function 
training in humans. Combinations of these activities the selection of an optimal schedule 
of activities to improve executive function deficits in humans. In this way, an effective 
virtual simulation model of executive function training activities could provide 
considerable time and cost savings compared to clinical studies for the optimization of 
training activity schedules in humans. 
1.2  Artificial Neural Networks 
Artificial neural networks (ANNs) are a group of computational models that are 
inspired by the structure and function of biological neural networks9. ANNs are composed 
of individual units that receive inputs, process these inputs, and produce an output, similar 
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to the way that individual neurons in biological neural networks receive, process, and 
produce electrical signals. Multiple units are combined into layers, and these layers are 
combined to form the full network. Each unit in a given layer receives multiple inputs 
produced by units in the previous layer, and produces a single output that is used as an 
input for multiple units in the next layer. The design of the units, layers, and their 
connectivity pattern is known as the network architecture. 
A single unit in an ANN consists of a set of parameters called weights and biases, 
a transfer function, and an activation function (Figure 1)9. Each unit possesses multiple 
weights (one for each input it receives), and a single bias value. The transfer function uses 
the unit’s weights and biases to combine a unit’s multiple inputs into a single net input 
value. The weights may be thought of as values that assign an importance to each input a 
unit receives, similar to the way that the strength of a neural synapse determines the 
influence that the outputs of a presynaptic neuron exert on a postsynaptic neuron. The bias 
parameter is included to allow a unit to produce an output in the absence of any inputs. A 
common transfer function uses an operation called the dot product to multiply each input 
by its corresponding weight parameter, and then sum these weighted inputs together. The 
bias value is then added to this sum to produce a single net input value for the unit, which 
is processed by the activation function to determine the output of the unit. 
ANNs have attracted interest as a computational model in drug development and 
healthcare because of their ability to learn how to accomplish tasks that involve the 
processing of complex input data. For example, ANNs have been used to predict the 
quantitative structure-activity relationships of potential drug candidates10, predict the 
occurrence of cardiovascular disease11, and screen for skin cancer12, diabetic retinopathy13, 
and other retinal diseases.14 This automation of complex tasks requiring specialized 
knowledge offers a significant potential advantage in time and cost savings. 
Before an ANN is able to perform a task effectively, it must first learn how to perform the 
task by completing a training procedure9. ANNs are part of a broader collection of 
computational techniques called machine learning algorithms, which are a set of 
computational models that learn how to complete tasks more accurately by performing the 
tasks on their own without explicit guidance from a human15. Machine learning methods 
are advantageous in that they allow for the automation of complex procedures where a 
model can learn how to perform a task on its own without explicit instructions for how to 
do so. There are three categories of training procedures: reinforcement learning, 
unsupervised learning, and supervised learning. While unsupervised and supervised 
learning involve the performance of a task on only a single example of training data at a 
given time, reinforcement learning involves the performance of multiple sequential actions 
within a complex environment to maximize total rewards. In reinforcement learning, the 
environment consists of a series of different states presented to the model (or “agent”) as 
inputs, where the agent makes a decision at each unique state and each decision is 
associated with a unique reward value16. After the initial step, each new state depends on 
the actions taken in the previous states, and each state may have a unique set of rewards 
associated with the possible decisions in the state. In this context, the agent is trained to 
make the best series of decisions as it proceeds through each state of the environment to 
maximize the total reward value received. A simple application of reinforcement learning 
is training an ANN to navigate a maze, and reinforcement learning techniques are of  
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Figure 1 – Structure of a computational unit in an Artificial Neural Network17 
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interest for developing navigation systems for autonomous vehicles18. 
In contrast to learning how to make multiple decisions in response to a series of 
related states with reinforcement learning, the models for unsupervised learning and 
supervised learning learn how to make single unrelated decisions in response to distinct, 
but possibly similar, inputs. Unsupervised and supervised learning differ in the quantity of 
information available with the training examples. In unsupervised learning, the training 
examples are presented without any information describing the correct response associated 
with them19. Clustering algorithms are an example of a computational technique using 
unsupervised learning. In clustering algorithms, data points are grouped into categories 
based on similarities in their features. The relevant features of the data points are not known 
in advance, and therefore the clustering algorithm must group the data points without any 
guidance for how to do so. 
In contrast, supervised learning training procedures include information about the 
correct response for a training example during its presentation to the ANN20 (Figure 2). In 
this case, the correct response (or training label) associated with a training example acts as 
a feedback mechanism to adjust the ANN’s performance on the task. The accuracy of an 
ANN’s response to a training example is determined by the ANN’s loss function, which 
measures the deviation between the ANN’s output and the correct response. The output of 
the loss function passes through each layer of the ANN in reverse order by the calculation 
of partial derivatives in a technique called backpropagation21. Eventually, backpropagation 
calculates the effect that all the weights and biases in the ANN exert on the loss function, 
and this result is used to adjust the values of each weight and bias in a manner that nudges 
the ANN’s response to a training example closer to the correct response indicated in the 
training label.  
A relatively simple variety of ANNs is a fully-connected feedforward network22 
(Figure 3). As its name implies, the fully-connected feedforward network possesses a full 
set of connections between each layer of units. In other words, each unit in a given layer 
receives an input from every unit in the preceding layer, and its output is passed on to every 
unit in the next layer. The term “feedforward” refers to the unidirectional forward flow of 
information through the ANN.  
An autoassociative memory network is a fully-connected feedforward network that 
is trained to reproduce the input data it receives as an output23-24. These networks are trained 
by supervised Hebbian learning, which is a variety of synaptic connection between two 
neurons when both neurons are activated in close succession25. Since it is able to produce 
a representation of an input that may be retained after the input is removed, the 
autoassociative memory network can potentially perform the short-term memory function 
of working memory within the scope of this project. 
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Figure 2 – The Supervised Learning Process for Artificial Neural Networks26 
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Figure 3 – Structure of a Fully-Connected Artificial Neural Network27 
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Another variety of feedforward network that does not possess a fully-connected 
structure is the convolutional neural network (CNN)28. A CNN is constructed from 
alternating convolutional and pooling layers. The convolutional layers consist of a set of 
sliding filters that learn how to detect relevant features in that layer’s input data. Each unit 
in a convolutional layer uses a filter to detect a feature in a sub-region of the input data, 
and therefore is not fully connected to the outputs of the previous layer. Each unit in a 
pooling layer in turn connects to a sub-region of the output of its preceding convolutional 
layer, and compresses all the values contained in this sub-region into a single value. The 
design of CNNs is inspired by the structure and function of the visual cortex, making them  
particularly useful for analyzing visual information. In this project, CNNs are utilized to 
serve as a representation for the information manipulation function of working memory.  
The varieties of ANNs discussed thus far are only capable of processing a single 
input at a time. A recurrent neural network (RNN)29, on the other hand, is capable of 
processing multiple inputs (or sequences) at one time. While an RNN uses a feedforward 
network structure to process the individual inputs in the sequence, it possesses a unique set 
of weight and bias values that define a distinct internal layer for each input in the sequence. 
A basic RNN determines the values of each internal layer from the values of the previous 
internal layer by a process called matrix multiplication. This procedure is limited in its 
usefulness for longer sequences of inputs, however, so an RNN called a Long Short-Term 
Memory network (LSTM)30 includes a set of gates between internal layers that allows for 
the “forgetting” of irrelevant information and improved performance. 
Due to their similarity to biological neural networks, ANNs could potentially be 
used as a computational model for neurological activity. This premise inspired the selection 
of ANNs as a computational tool to simulate the training of executive functions in this 
project. Importantly, the neurological activities of interest in this project are the neural 
adaptations that occur during learning processes, rather than the actual function of neurons 
during mental processes. It is hypothesized that ANNs can be trained to perform virtual 
tasks that resemble activities in humans that require the use of executive functions, and that 
this training process can provide insight into the optimal way to train the use of executive 
functions in humans.  
1.3 Attention Deficit Hyperactivity Disorder 
Attention deficit hyperactivity disorder is a neurodevelopmental disorder 
characterized by inattention, hyperactivity, and impulsivity31. The onset of ADHD 
typically occurs by 3 years of age, and must occur by 12 years of age for a diagnosis. While 
symptom severity decreases with age, ADHD may persist into adulthood32, when the 
hyperactive-impulsive symptoms typically subside but the inattentive symptoms persist33. 
The American Psychiatric Association’s Diagnostic and Statistical Manual, Fifth Edition 
(DSM-5) has identified three ADHD subtypes: predominantly inattentive, predominantly 
hyperactive-impulsive, and combined type. Diagnosis of the predominantly inattentive and 
predominantly hyperactive/impulsive subtypes requires the presence of at least six of their 
respective symptoms (listed below) for at least six months. These symptoms must be 
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present in at least two settings, and cause clinically significant distress or impairment in 
social, academic, or occupational functioning34. The combined subtype requires the 
presence of at least six symptoms from both the predominantly inattentive and 
predominantly hyperactive/impulsive subtypes for at least six months. 
Inattentive Symptoms: 
● Often fails to give close attention to details or makes careless mistakes in 
schoolwork, at work, or during other activities (e.g., overlooks or misses details, 
work is inaccurate). 
● Often has difficulty sustaining attention in tasks or play activities (e.g., has 
difficulty remaining focused during lectures, conversations, or lengthy reading). 
● Often does not seem to listen when spoken to directly (e.g., mind seems elsewhere, 
even in the absence of any obvious distraction). 
● Often does not follow through on instructions and fails to finish schoolwork, 
chores, or duties in the workplace (e.g., starts tasks but quickly loses focus and is 
easily sidetracked). 
● Often has difficulty organizing tasks and activities (e.g., difficulty managing 
sequential tasks; difficulty keeping materials and belongings in order; messy, 
disorganized work; has poor time management; fails to meet deadlines). 
● Often avoids, dislikes, or is reluctant to engage in tasks that require sustained 
mental effort (e.g., schoolwork or homework; for older adolescents and adults, 
preparing reports, completing forms, reviewing lengthy papers). 
● Often loses things necessary for tasks or activities (e.g., school materials, pencils, 
books, tools, wallets, keys, paperwork, eyeglasses, mobile telephones). 
● Is often easily distracted by extraneous stimuli (for older adolescents and adults, 
may include unrelated thoughts). 
● Is often forgetful in daily activities (e.g., doing chores, running errands; for older 
adolescents and adults, returning calls, paying bills, keeping appointments). 
 
Hyperactive/Impulsive Symptoms: 
● Often fidgets with or taps hands or feet or squirms in seat. 
● Often leaves seat in situations when remaining seated is expected (e.g., leaves his 
or her place in the classroom, in the office or other workplace, or in other situations 
that require remaining in place). 
● Often runs about or climbs in situations where it is inappropriate. (Note: In 
adolescents or adults, may be limited to feeling restless.) 
● Often unable to play or engage in leisure activities quietly. 
● Is often “on the go,” acting as if “driven by a motor” (e.g., is unable to be or 
uncomfortable being still for extended time, as in restaurants, meetings; may be 
experienced by others as being restless or difficult to keep up with). 
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● Often talks excessively. 
● Often blurts out an answer before a question has been completed (e.g., completes 
people’s sentences; cannot wait for turn in conversation). 
● Often has difficulty waiting his or her turn (e.g., while waiting in line). 
● Often interrupts or intrudes on others (e.g., butts into conversations, games, or 
activities; may start using other people’s things without asking or receiving 
permission; for adolescents and adults, may intrude into or take over what others 
are doing). 
Both the number of children diagnosed with ADHD and the use of stimulant 
medications for its treatment has been rising in recent years. The overall prevalence of 
ADHD increased from 6.1% in 1997-1998 to 10.2% in 2015-2016. The prevalence in boys 
increased from 9.0% to 14.0%, while the prevalence in girls more than doubled from 3.1% 
to 6.3%. However, it is unknown at this time whether these increases reflect the actual 
number of ADHD cases, or are instead a result of factors leading to increased diagnosis of 
ADHD, such as increased physician awareness, changes in diagnostic criteria, or increased 
access to medical care35. In 2011, 3.5 million children were being treated with stimulants 
according to parents36. In addition, prescriptions for ADHD meds in women of child-
bearing age increased by 344% from 2003 to 2015, which included a 700% increase in 
women of ages 25-29 years and a 560% increase in women of age 30-34 years37. 
The causes of ADHD remain largely unknown, although environmental factors and 
genetic risk factors are known to be involved. Potential environmental risk factors for the 
development of ADHD include fetal development, diet, and family interactions38. The risk 
factors related to fetal development include prenatal smoking39, premature birth40, and low 
birth weight41. However, the increased risk due to prenatal smoking may be due to other 
environmental confounders38, and the increased risk observed from premature birth may 
actually be due to the low birth weight of children who are born preterm41. Dietary risk 
factors include deficiencies in fatty acids42, zinc43, and iron44, as well as the intake of 
artificial food colorings45. The observed nutritional deficiencies may be due to altered 
nutrient metabolism in children with ADHD rather than dietary intake, however46. Finally, 
risk factors related to family interactions include parenting behaviors and early deprivation 
and neglect38. Although difficult family environments and adverse parenting behaviors 
have been associated with ADHD47-49, it remains uncertain whether these risk factors are 
actually a causative factor of ADHD, or whether they result from the behavior of children 
with ADHD38. However, early deprivation and neglect50 has shown stronger evidence of a 
causative role. 
Factors that protect against negative outcomes in children with ADHD have also 
been identified, although this area of research is relatively recent so the scope of findings 
is limited (for review, see Ref. 51). These factors are psychosocial, and can be classified 
as personal factors, family factors, and social factors. Coping self-efficacy52, a sense of 
competence51, and a sense of optimism and control53 are personal factors that protect 
against negative outcomes in ADHD. Family factors include family cohesion54, parenting 
style55-56, parenting skill57, and parental affection58-59. Social factors include friendship 
presence60, friendship intimacy61, and peer acceptance51,62. The effects of these factors have 
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been discovered in cross sectional studies and longitudinal studies of limited duration51, so 
the long-term persistence of the protective effects over time has not yet been established. 
With an estimated heritability rate of 0.763, genetic influences also play a 
considerable role in the development of ADHD. Investigations into genetic factors of 
ADHD have so far revealed modest associations for the dopamine transporter (DAT1), 
dopamine receptors D4 & D5 (DRD4, DRD4), and the serotonin transporter (5HTT)64. 
Therefore, many other unknown genetic variants likely interact with these genes to produce 
the observed large heritability rate65.  
Pharmacologic therapies are widely used to treat ADHD and have proven effective 
in controlling ADHD symptoms. The most commonly used pharmacologic treatments 
include stimulants (methylphenidate and amphetamine salts), a norepinephrine reuptake 
inhibitor (atomoxetine), and alpha-2 adrenergic agonists (clonidine and guanfacine)66. Of 
these, stimulants are the most efficacious and are recommended for use as the first-line 
treatment option66. Stimulants increase release of the neurotransmitters norepinephrine and 
dopamine release into neuronal synapses, primarily from binding to the dopamine 
transporter (DAT1)67. DAT1 is a membrane protein located in the presynaptic terminal of 
dopaminergic neurons, and terminates the action of dopamine and norepinephrine on 
postsynaptic neurons by transferring them from the neural synapse back into presynaptic 
nerve terminals68. While methylphenidate binding inhibits DAT1’s reuptake activity, 
amphetamine reverses the direction of DAT1’s neurotransmitter transport function. In 
other words, methylphenidate prevents removal of dopamine and norepinephrine from the 
synapse, while amphetamine both prevents the removal of dopamine and norepinephrine 
and increases its release from the presynaptic neuron via reversed function of DAT1. In 
addition, amphetamine displaces dopamine and norepinephrine from synaptic vesicles to 
increase their available cytosolic concentration for reverse transport by DAT1 into the 
synapse. The overall effect of stimulants is to increase synaptic levels of dopamine and 
norepinephrine, and increase their availability for signaling to post-synaptic neurons. 
Atomoxetine binds to and inhibits the function of the norepinephrine transporter 
protein, which removes norepinephrine from neuronal synapses in a manner similar to 
DAT1’s uptake of dopamine67. Alpha-2 adrenergic agonists enhance the action of the 
alpha-2 G-protein coupled receptor located in the presynaptic terminals of sympathetic 
neurons67. The alpha-2 receptor binds to the inhibitory Gi-protein; the stimulation of this 
receptor decreases neurotransmitter release from sympathetic neurons, resulting in a 
reduction in the overall level of sympathetic neurotransmission. 
Despite the variety of pharmacologic treatment options available and their 
widespread use, there still remains a strong need to develop additional therapies69. While a 
general consensus exists for the efficacy of stimulants, a recent systematic review of 
methylphenidate concluded that the evidence supporting its use is of very low-quality, and 
more caution should be exercised in its use70. However, the benefits that do result from 
stimulant use do not persist after discontinuation and patients with ADHD still suffer from 
adverse long-term outcomes such as poor academic performance, drug addiction, and 
criminal behavior to a much greater degree than non-ADHD subjects despite optimal 
therapy71. Despite their tolerability in a majority of ADHD patients, the side effect profile 
of stimulants (anxiety, irritability, insomnia, gastrointestinal distress, loss of appetite, and 
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growth suppression) still precludes their use in a significant number of patients due to the 
widespread need for their use. An additional safety concern of stimulants are their long-
term effects, for which there is a paucity of research in humans. However, two recent 
studies have shown altered cerebral blood flow responses after discontinuation of stimulant 
use72 and reduced GABA levels in the pre-frontal cortex of ADHD patients who were 
treated with stimulants at a young age73. Drug treatments also suffer from further under-
utilization due to parents’ concerns about their safety and preference for the use of non-
drug treatments69. Finally, the widespread use of stimulants has also led to their misuse and 
abuse for non-medical purposes, which may be obviated by a greater availability of other 
effective treatments for ADHD. 
An alternative treatment strategy for ADHD attracting wide interest is the targeting 
of neuropsychological functioning, such as executive function impairments. Russell A. 
Barkley proposed an executive function theory for ADHD in 1997, which states that an 
impairment in the core executive function inhibition is the central causative factor in the 
development of ADHD7. Since the hyperactive behavior of children with ADHD reflects a 
lack of behavioral inhibition and the use of inhibition keeps attentional resources available 
for the use of other executive functions, Barkley reasoned that a deficit in inhibition leads 
to a cascade of impairments in other executive functions culminating in the characteristic 
behavior of ADHD.  
As discussed in Chapter 2, computerized training programs (including video 
games) have drawn interest as a tool to train executive function deficits. Our lab is currently 
conducting a pilot study of the online game Minecraft as a therapeutic video game (TVG) 
to train executive function deficits in children with ADHD (Chapter 3). The effects of the 
TVG intervention in combination with stimulants is being investigated to develop a 
combination therapy that can address both the dopaminergic dysfunction and executive 
function deficits in ADHD. Although the results of this study will be used to guide the 
clinical development process, additional guidance for the optimization of the executive 
function training activities will be provided by the computational model of executive 
functions currently under development. This model is using ANNs to complete virtual tasks 
that resemble the tasks that subjects with ADHD complete in the Minecraft world, and the 
schedule of virtual tasks that result in maximum improvements in ANN function will 
determine the selection of training regimens in future clinical studies.  
An orphan drug indication for a drug/device combination of stimulants with the 
therapeutic video game will be pursued for the treatment of ADHD-like symptoms in 
Fragile X Syndrome (FXS)74. FXS is a rare genetic disorder and is the most common form 
of inheritable mental retardation. Most commonly, FXS is caused by an excess quantity of 
CGG-nucleotide repeats (>200) in the 5’-untranslated region of the fragile X mental 
retardation 1 (FMR1) gene located on the X-chromosome. The expanded set of CGG-
nucleotide repeats leads to hypermethylation and silencing of the FMR1 gene, and 
decreased production of the fragile X mental retardation 1 protein (FMRP).   
The estimated prevalence of FXS is 1 in 4,00075, which qualifies this disorder for 
the FDA’s Orphan Drug Designation Program that promotes accelerated drug development 
for rare diseases76. ADHD symptoms are present in 80% of FXS patients, which can be 
treated with stimulants and alpha-2 adrenergic agonists77-78. However, stimulants show 
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efficacy in approximately 60% of FXS patient79, so drug therapy could potentially be 
improved by the combination of stimulants with a therapeutic video game. 
This intervention will utilize a novel personalized medicine approach where an 
individualized treatment regimen consisting of an initial stimulant dose recommendation 
and schedule of therapeutic video game activities will be determined from the initial 
ADHD assessment results of new patients. We hypothesize that the training of ANNs can 
serve as a computational model for the adaptations that biological neural networks undergo 
in response to practicing of activities requiring the use of executive functions.  In the model, 
a set of ANNs will first be trained to resemble the pattern of executive function deficits 
reflected in a new patient’s assessment responses. A large set of virtual tasks resembling 
the therapeutic video game activities will be tested in the model, and the set of virtual tasks 
that produces the maximum improvements in the ANNs of the virtual “subject” will predict 
the analogous set of therapeutic video game tasks most beneficial for the human patient. A 
future clinical study will test this hypothesis by including an experimental group with a 
personalized executive function activity training schedule guided by the computational 
model that will be compared with a control group completing an executive function activity 
training intervention that is not guided by the computational model. 
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CHAPTER 2. ADHD, PHARMACEUTICALS, AND VIDEO GAMES 
2.1 Attention Deficit Hyperactivity Disorder 
Diagnosis rates of ADHD in children range from 3-11% compared to 4% in 
adults80-82. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5 
million children were being treated with therapeutics as reported by their parents81. 
Stimulant medications such as amphetamines and methylphenidate are currently the first-
line treatment for ADHD66, although there are significant problems associated with their 
use. They are often misused, abused, and diverted for nonmedical purposes. Stimulant use 
is associated with, and, in many cases, limited by, side effects such as insomnia, 
gastrointestinal distress, irritability, loss of appetite, and growth suppression66. Parents also 
have poor perceptions of their safety69,85-86, and thus they remain underutilized as a 
treatment option in children69,85-86. Although these medications are effective in controlling 
symptoms in the short term in many patients, their efficacy does not persist after 
discontinuation71, many patients may experience only a partial response or no response at 
all87-88, and, even with treatment, children with ADHD still suffer from greater rates of 
adverse long-term outcomes such as drug abuse and criminal behavior than healthy 
children71. 
2.2 Pharmacotherapy 
Pharmaceutical therapy with stimulants is the most effective monotherapy for most 
patients with ADHD, with the exception of the very young89. The advantages of combining 
pharmaceutical therapy with behavioral therapy include lower cost, as personnel time with 
patients is reduced, and reduced doses of pharmaceuticals (50-75%)90. Additionally, the 
benefits of behavior therapy are more likely to carry forward once treatment has stopped90. 
Behavior therapy for ADHD patients includes repetitively reducing negative behaviors 
with consequences and increasing positive behaviors with rewards89. However, behavior 
therapy is not widely available to all patients, and its benefits are limited to the targeted 
behaviors only71. 
2.3 Video Games 
A potential alternative approach to address these issues is to improve the cognitive 
processes that underlie the observed symptoms71. One potential intervention target to do 
so is executive function, which is a set of top-down mental processes that regulate 
distracting influences and automatic, unproductive behaviors to enable self-control1. 
Training of the core executive function working memory has previously been shown to 
increase cortical D1 receptor density91. As dopaminergic function is compromised in 
ADHD92, these alterations could provide additional benefits in improving the function of 
patients with ADHD. To this end, computer-based programs with repeated cognitive 
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exercises without video game elements have been used as a treatment intervention in 
ADHD93. However, it is thought that delivery of these interventions in a video game format 
can help improve their effects by promoting a state of optimal cognitive performance and 
increasing the participant’s focus and motivation to complete them93. Indeed, children with 
ADHD have shown reduced impairments in inhibition (but not working memory) while 
playing video games94, and the addition of video game elements to executive function 
training tasks have resulted in improvement of working memory95-96 as well as improved 
working memory performance over time96. 
In addition, training methods used to enhance learning have traditionally shown 
effects only in the specific areas targeted by the training97. However, healthy action video 
game players have outperformed non-players in a broad variety of cognitive performance 
measures, including some executive functions such as flexibility and top-down attention, 
suggesting their potential usefulness as a cognitive training tool97. Notably, improvements 
in these areas have been seen in randomized, controlled trials of non-players trained with 
either an action video game or a non-action video game (as an active control group) in the 
action video game group only, suggesting that action video games have a causative role on 
this improved performance97. Furthermore, video gaming may be able to increase 
motivation and one’s ability to learn98. This effect is thought to be mediated by games 
producing increased striatal dopamine levels99-100 that enhance long-term potentiation of 
neural connections in the striatum101. The potential of using a video game as a therapeutic 
tool was further evidenced in a recent article in the journal Nature that described a video 
game training multitasking ability that was capable of improving measures of the 
neurological functions that underlie cognitive control in elderly subjects102. Thus, by using 
a video-game based cognitive training intervention as part of a drug/device combination 
with stimulants, it could be possible to increase the efficacy of currently available 
treatments and/or reduce the dose of stimulants needed to control symptoms. 
However, video game play has also been associated with several adverse effects. 
Like pharmaceuticals, the effect seen seems to be related to the amount and style of video 
games to which humans are exposed. First-person shooter games with violence have been 
associated with anxiety and fear103. However, these associations have been found in 
subjects with excessive video game use or internet gaming addiction,104-112 (but see Ref. 
113) and it is thought that the excessive gaming could be used as a form of escape from 
negative emotions rather than a causative factor for them107-108,111 (but see Ref. 109). The 
negative outcomes of video game play include obesity, aggressiveness, antisocial behavior, 
and addiction103. Although video games could potentially be advantageous as a learning 
aid, increased time spent playing video games has been associated with worse academic 
performance114. Despite these concerns, there have not been any significant safety concerns 
reported in studies using video games for executive function training. Thus, we suspect 
that video game play using a schedule similar to the training interventions that have 
resulted in improved executive function will still have a favorable safety profile compared 
to pharmaceutical treatments. 
Recognizing the therapeutic potential of video games, the FDA has issued a 
guidance for therapeutic video app developers. Pfizer and Shire Pharmaceuticals are 
funding research in video games, and companies like CogCubed and Akili are developing 
video games for approval as FDA-regulated devices. Although drug companies are 
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currently seeking prescription video games, they must eventually move toward drug/device 
combinations to increase efficacy. 
Most studies investigating executive function training in children with ADHD have 
targeting single executive function only, mostly working memory. Visuospatial working 
memory is considered the most important neuropsychological deficit in children with 
ADHD115 and training of working memory has been shown to alter cortical dopamine D1 
receptor density91. A recent meta-analysis concluded that the use of cognitive training 
interventions targeting working memory or attention alone have resulted in substantial 
improvement in these executive functions, with some studies also showing improvements 
in parent ratings of ADHD symptoms88. The improvements in working memory have been 
shown to persist at 6 months116-117 and 8 months118 after completion of training. However, 
far transfer effects to functional areas beyond the targeted executive functions (such as 
improvements in academic measures) and teacher ratings of ADHD symptoms have 
remained largely unaffected119-121. These inconsistencies could potentially be due to 
practice effects resulting from repeated assessments affecting the executive function 
measures and insufficient blinding procedures affecting parents’ ratings88. 
The scope of research involving cognitive training interventions targeting multiple 
executive functions is more limited than for those targeting a single executive function. 
However, studies investigating interventions targeting multiple executive functions have 
shown a greater magnitude in improvement of ADHD symptoms assessed by parents 
compared to those targeting a single executive function88,115,122-125. Although these 
improved effects could be due to an increased duration of training, it is possible that 
training strategies targeting a broader set of executive functions may be required to 
effectively address both the full spectrum of neuropsychological deficits present in ADHD 
as well as the inter-individual variation of deficits among children with ADHD88. 
With regard to ADHD symptom assessments by blinded raters, two recent studies 
investigating an intervention with added video game elements to simultaneously train 
multiple executive functions showed effects in teacher-rated outcomes. One intervention 
training working memory, inhibition, and flexibility was able to produce moderate-to-large 
improvements in ADHD symptoms ratings by teachers, but these effects were also obtained 
with the placebo intervention, suggesting that the improvements were due to general 
features of the intervention not related to the executive function training itself98. Another 
intervention training time management, organization/planning, and cooperation resulted in 
small-to-moderate improvements of parent-reported daily functioning in the areas of 
working memory, time management, and responsibility126. Improvements in time 
management were also reported by teachers in this study, suggesting that training 
interventions targeting skills that are directly applicable in daily life could potentially 
improve far transfer effects across multiple settings126. 
Therefore, there is still a need to further explore the potential of using video gaming 
interventions to train multiple executive functions, including those that are directly utilized 
in daily life, as a treatment for ADHD. Our laboratory is currently conducting a pilot 
clinical study investigating the use of the popular online game known as Minecraft in 
combination with stimulant medications in subjects with ADHD. Minecraft is an online 
video game containing a “virtual land where users can create their own worlds and 
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experiences, using building blocks, resources discovered on the site and their own 
creativity” that requires its users to apply problem solving, planning, and organizational 
skills for creative building and exploration127. It has many levels of difficulty, which allows 
for adaptation to users with a wide range of cognitive abilities as well as potential for 
incremental progressions in difficulty as the user’s performance improves. Minecraft is 
widely available across a variety of commonly used devices, its recommended age range 
and content is appropriate for children, and its online world allows considerable flexibility 
for designing a variety of activities that challenge executive functions. In Survival Mode, 
Minecraft becomes an action game that should carry action game benefits. 
One possible mechanism of action associated with the effects of Minecraft on 
ADHD is the opportunity for reinforcement of positive behavior and punishment for 
negative behaviors provided by Minecraft. Minecraft is an online medium with several 
built-in components similar to behavior therapy exercises but enjoyable so that children 
want to play. High performance in several major executive functions noted to be lacking 
in ADHD children is positively reinforced by gameplay, in that success yields completion 
of a specific task, acquisition of a rare in-game item, or even character survival in a given 
situation. Furthermore, Minecraft allows players to re-attempt failed challenges as 
characters re-spawn after death, though with certain disadvantages. This both gives players 
the impetus to improve in those executive functions (to prevent character death or hassle) 
and the ability to continue improving. 
In contrast to the behavioral training components of Minecraft, the training of 
executive function is expected to yield more generalizable benefits across multiple 
environments, because executive function processes underlie all cognitive processes while 
training to modify behaviors can only affect the specific behaviors targeted69. In order to 
direct the practice of executive functions, during this trial players are required to work from 
an activity list with additional reinforcement for practicing behavior therapy type activities. 
The activity list includes two tasks of increasing difficulty for each of the following 
executive function skills: planning, time management, self-regulation, sustained attention, 
organization, response inhibition, working memory, goal-directed persistence, flexibility, 
and metacognition. A self-assessment component of the trial provides an additional 
opportunity to encourage subjects to develop metacognition. Thus, the training activities 
address both the underlying core executive functions (working memory, inhibition, and 
cognitive flexibility), as well as executive function skills utilized in school and work 
settings (planning, time management, self-regulation, sustained attention, organization, 
goal-directed persistence, and metacognition). 
The primary objective of this trial is to derive a functional relationship between 
NICHQ scores (an assessment that measures ADHD symptoms as well as the patient’s 
function in everyday life), game aspects of Minecraft, and executive function. All patients 
in this study are required to be on stimulant drugs, so the effects of varying stimulant doses 
on the changes in executive function can also be explored. The development of this 
functional relationship could ultimately enable a personalized medicine approach to the 
treatment of ADHD by identifying the executive functions where an individual is most 
deficient and predicting the stimulant drug dosage and nature and schedule of the Minecraft 
activities that would be most effective for treating these deficits. This strategy could 
potentially improve the efficacy of treatment by targeting each patient’s unique deficits, as 
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well as reduce the time to achieve optimal treatment effects by using artificial neural 
networks to simulate the patients’ Minecraft therapy (Neural networks can be programmed 
to perform tasks in Minecraft faster than humans). 
The executive function deficits are assessed by a patient’s pattern of responses on 
the NICHQ assessment, and the nature and schedule of the Minecraft activities used to 
correct these deficits predicted by a computational model utilizing artificial neural 
networks (ANNs). Artificial neural networks are a computational technique inspired by the 
structure and function of biological neural networks and categorized under the headings of 
artificial intelligence and machine learning. Due to their similarity to biological neural 
structures, it is possible that the learning processes that occur during the training of an ANN 
could be used to simulate the learning processes that occur in human subjects from the 
completion of cognitively demanding tasks. An abbreviated “NICHQ” which assesses 
behavior that can be appropriately observed in the context of the computational model will 
be used to measure changes of executive functioning within the model that result from the 
application of computational tasks that are similar to the Minecraft activities that the human 
subjects perform. Separate models will be developed with ANNs that show poor 
performance (ADHD-ANNs) and relatively good performance (control-ANNs) on these 
tasks. Modifications of these tasks will also be tested in this manner to determine how 
optimal performance improvements in the ADHD-ANNs can be produced. Finally, these 
modified tasks will be tested in a future clinical study to determine the external validity of 
the model. 
The structure of these computational models will be based on three of the core 
executive functions: inhibitory control, working memory, and cognitive flexibility1. 
Inhibitory control refers to the ability to suppress the influence of internal or external forces 
that distract one from accomplishing a goal.3-4 Inhibitory control works closely together 
with working memory1, which is the ability to hold information in mind after it is no longer 
perceptually present and effectively manipulate it as desired2. For example, using working 
memory to focus attention on accomplishing a goal helps to remove attention from 
distracting impulses. Similarly, using inhibitory control to focus attention away from 
distracting impulses supports the use of working memory by leaving more mental “working 
space” available to be directed towards accomplishing a goal. Cognitive flexibility5 
involves the ability to change perspectives, which requires the simultaneous use of both 
inhibitory control and working memory, where inhibitory control is used to resist the 
influence of one’s current perspective on their actions and working memory is used to hold 
a new perspective in attention to change one’s actions accordingly1. 
The first of the core executive functions, inhibitory control, is represented by an 
“Impulsivity” function, the value of which will increase over time and result in the 
activation of a distracting activity once its value increases above a given threshold. An 
ANN will be able to modify the parameters of this Impulsivity function, and a repeatedly 
executed training procedure will be implemented where the ANN will learn to modify these 
parameters more effectively to prevent the distraction function from activating as training 
proceeds. 
Secondly, working memory will utilize this inhibitory control structure, but with 
the inclusion of a “Goal Activation” function and a working memory mental space. This 
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function will work similar to the Impulsivity function, but if its value crosses a given 
threshold, then a goal activity function will be activated (as opposed to the distractor 
activity function). The working memory mental space will be represented by immediate 
computer memory, where function instructions (for either the goal or distracting activity) 
and the values of their associated parameters can be efficiently accessed and manipulated 
by the CPU. In this case, the implemented training procedure will be designed such that 
the ANN will learn to simultaneously modify the parameters of both the Impulsivity and 
the Goal Activation function to more effectively devote computational resources towards 
the completion of the goal activity and consequently complete the appropriate task function 
more efficiently. 
Finally, cognitive flexibility will utilize the described interaction between 
inhibitory control and working memory, but at a given time point, the conditions of the 
task shall be changed such that activities other than the goal activity are to be performed 
for a given time period. Eventually, the conditions will be switched back so that the goal 
activity is to be completed once again, and this pattern will then be repeated in a cyclical 
manner. When computational resources are to be focused on the goal activity, the training 
of the ANN will involve diminishing the value of the Impulsivity function while increasing 
the value of the Goal Activator function as described above. However, when the conditions 
of the task change such that the goal activity is not to be pursued, the training of the ANN 
will be altered to instead increase the value of the Impulsivity function while diminishing 
the value of the Goal Activator function. An effectively trained ANN for cognitive 
flexibility will be able to more rapidly perform these transitions, and devote computational 
power towards the goal only when appropriate based on the given conditions. 
2.4 Preliminary Feasibility Study 
A preliminary study was conducted to determine the feasibility of performing a 
basic simulation of a working memory deficit in an ANN. For this experiment, a 
convolutional neural network (commonly used in image recognition applications) was 
utilized to identify images of handwritten digits from the MNIST database. The MNIST 
database is a publicly available database that contains a training set of 60,000 image files 
and a test set of 10,000 image files of handwritten numbers, each with a label identifying 
the correct number contained in the image8. The training set is used to present the ANNs 
with examples from which to “learn” how to identify handwritten digits, while the test set 
is used to measure the performance of the ANN in identify the digits after training has been 
completed. This dataset is a commonly used tool to benchmark the performance of ANNs 
in image recognition applications. 
Wolfram Mathematica v11.1 was used for all calculations. Two ANNs of identical 
convolutional structure, but differing in training procedures, were used in this study. The 
first ANN was trained with the full MNIST training set and represented a “healthy” control 
condition, while the second ANN was trained with a truncated form of the MNIST training 
set and represented an experimental “ADHD” condition with a working memory 
deficiency. The test set consisted of randomly selected images that were not included in 
the training sets, and the performance of the trained ANNs was tested on six different test 
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sets consisting of ten images each. The control ANN achieved 100% (SD 0%) correct 
recognition of handwritten digits in sample images taken from the MNIST test set, while 
the working memory-deficient ADHD-ANN achieved only 50% (SD 8.9%) correct 
recognition of sample images taken from the MNIST test set (Figure 4). 
Two examples of working memory (the ability to hold information in one’s 
attention and manipulate it) include mentally relating information to derive a general 
principle or to see relations between items or ideas, and incorporating new information into 
one’s thinking or action plans1. The truncated training procedure represented a lack of 
attention in the ADHD-ANN that led to its failure to derive the general principles and see 
the proper relations between the images of handwritten digits and the number that they 
contain. This deficiency was reflected in the ADHD-ANN’s inability to correctly identify 
digits in the test set, which represented a failure to properly incorporate new information 
into one’s thinking. Furthermore, since the ANNs were of identical structure, and differed 
only in the training procedure, any differences in their performance would be interpreted 
as being due to an environmental (rather than genetic) effect. 
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Figure 4 - Working Memory Deficit Preliminary Study Results 
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2.5 Conclusion 
This work is an extensively simplified model of working memory, but future work 
will focus on increasing its complexity. First, the modeling of working memory can be 
improved by requiring the ANNs to make more complex manipulations of their input 
images. For example, the ANNs can be trained to receive two image files with handwritten 
numbers as an input, and then output the sum of these numbers. Alternatively, they could 
be presented with image files containing handwritten words as inputs, and trained to output 
these words spelled backwards. 
Next, an additional task will be included (distractor activity) to model the 
interaction of working memory plus inhibition, as well as cognitive flexibility. This task 
will be a similar simple image identification task at first, such as identifying objects 
contained in photographs, rather than handwritten numbers. To model the interaction of 
working memory with inhibition, these models will first include the Impulsivity function 
discussed earlier that is promoting the second distractor activity task. Then, to model 
cognitive flexibility the ANNs will be required to switch their focus between the goal & 
distractor functions at a given time interval. Finally, the complexity of the model will be 
increased by using multiple ANNs in larger algorithms to model the more complex 
executive function skills, such as planning or time management. 
The use of this variety of ANN as a working memory model is not ideal from a 
neurobiological perspective since working memory function has been linked to dorsolateral 
prefrontal cortex activity4, which possesses a distinct structure and connectivity pattern 
from the visual cortex. Despite the structural dissimilarities of CNNs with the prefrontal 
cortex, working memory also relies on the cerebellum128 where supervised learning 
processes are active129, and therefore CNNs may nonetheless be useful for modeling 
adaptations of working memory function even if they are not capable of accurately 
representing working memory function itself. 
It will likely not be possible to capture the full complexity of executive function 
processes with this approach. Nevertheless, it could be possible to develop this model to 
the extent that it would provide some degree of utility for gaining insights into how 
modifications of training tasks can affect performance of their targeted executive functions. 
This utilization of ANNs to optimize a therapeutic intervention in the drug development 
process would be a novel application that could result in considerable savings in time and 
resources over the trial-and-error process for optimizing therapy that is now the standard 
approach. 
  
 
 
CHAPTER 3. A PILOT STUDY OF A DEVICE AND DRUG THERAPY FOR ADHD 
3.1 Introduction & Background 
3.1.1 Background Information 
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder 
characterized by difficulty paying attention, impulsivity, and hyperactivity. The medical 
community has been largely unable to standardize an accepted definition of ADHD as 
indicated by the medical community′s differing definitions according to Diagnostic and 
Statistical Manual of Mental Disorders, 5th edition (DSM-5)130 and the International 
Classification of Mental and Behavioural Disorders 10th revision (ICD-10)131. ICD-10 
refers to disorders in this area as hyperkinetic disorders rather than attention deficit and 
relies upon hyperactivity to distinguish ADHD from other disorders. The DSM-5 separates 
patient phenotypes into three differing presentations: predominantly inattentive-type, 
predominantly hyperactive-impulsive type, and combined inattentive hyperactive-
impulsive. Diagnosis of ADHD is predominantly based upon patient, teacher and parent 
responses to standardized questionnaires containing questions based on a list of criteria for 
diagnosing ADHD. People with ADHD are expected to have experienced at least six 
symptoms of inattention (predominantly inattentive-type), or hyperactivity (predominantly 
hyperactive-impulsive type), or both (combined) within the six months previous to the time 
of the assessment. 
In this study, we will use specially designed training activities performed within 
the environment of the popular computer game Minecraft to determine if they affect 
executive function, working memory, and restraint in patients diagnosed with ADHD. 
Various cognitive training interventions are currently under investigation for their effects 
on improving deficits in executive function in ADHD, and the addition of gaming elements 
to the cognitive training may help improve outcomes (for review, see Ref 93 P. 5-9). For 
example, utilization of a video game format to train biofeedback skills (reduction of heart 
rate through slowed breathing) in children with ADHD resulted in improved scores on the 
ADHD Questionnaire and the Strengths and Difficulties Questionnaire132. Gamification of 
the Conners Continuous Performance Test II, used to measure sustained attention, resulted 
in significant improvements in performance compared to the regular test in children with 
ADHD133. The addition of gaming elements to standardized working memory training 
tasks resulted in significantly improved motivation, training performance, and working 
memory of children with ADHD95 and the use of a gaming task also normalized task 
persistence in ADHD children in a visuospatial working memory task96. Finally, a multiple 
domain executive function training game resulted in improvements in the specific domains 
trained (inhibition, visuospatial short-term memory, and visuospatial working memory) in 
children with ADHD, although no benefits were seen in overall behavior ratings98. 
3.1.2 Rationale 
3.1.2.1 Rationale for use of stimulant-type medications to treat ADHD 
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Amphetamines are non-catecholamine sympathomimetic amines with CNS 
stimulant activity. The mode of therapeutic action in ADHD is not known, but 
amphetamines increase extracellular dopamine and norepinephrine. These alterations in 
extracellular neurotransmitters are a result of amphetamine's inhibition of the Dopamine 
Transporter (DAT), Norepinephrine Transporter (NET), Vesicular Monoamine 
Transporter-2 (VMAT- 2), and Monoamine Oxidase (MAO). 
DAT and NET are located in the presynaptic terminal cell membrane, where they 
function to clear dopamine and norepinephrine, respectively, from the synaptic cleft into 
the presynaptic neuron. This clearance is necessary to end the response of the postsynaptic 
neuron and recycle the neurotransmitters in the presynaptic neuron for subsequent 
repackaging and release. Thus, competitive inhibition of DAT by amphetamine prolongs 
the presence of dopamine in the synapse, which results in a greater degree of dopamine 
signaling to the postsynaptic cell. In addition to competitive inhibition of DAT function, 
amphetamine can reverse the direction in which dopamine is transported. This effect can 
further increase synaptic dopamine levels beyond the level resulting from transport 
inhibition alone. Although NET primarily uses norepinephrine as a substrate, it is also 
capable of transporting dopamine and its inhibition can increase synaptic dopamine 
levels134. 
While DAT and NET are located in the presynaptic cell membrane, VMAT2 and 
MAO are located within the presynaptic nerve terminal. VMAT2 is responsible for 
transporting monoamine neurotransmitters into vesicles within the nerve terminal, after 
which they can be released into the synaptic cleft. When VMAT2 is inhibited by 
amphetamine, cytosolic dopamine levels will increase. The increased cytosolic dopamine 
can then be acted on by the "reversed" DAT and transported into the synaptic cleft. 
However, while in the cytosol, dopamine is also susceptible to oxidative degradation by 
MAO. By inhibiting MAO function, amphetamine prevents this degradation and leaves 
increased cytosolic dopamine available for transport into the synaptic cleft67. In contrast, 
methylphenidate inhibits DAT and NET and has weaker inhibition of MAO than 
amphetamine67. Thus, methylphenidate increases extracellular dopamine levels by 
blocking its reuptake only, rather than also increasing its release as amphetamine does135. 
3.1.2.2 Rationale for use of Minecraft as add-on therapy to stimulant type ADHD 
medications 
Diagnosis rates of ADHD in children range from 5-11% compared to 2.5% in 
adults80-82. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5 
million children were being treated with therapeutics as reported by their parents81. One of 
the issues with continued reliance upon therapeutics to treat ADHD is that increased 
availability tends to increase nonmedical use of amphetamine-type ADHD drugs by 
adolescents and young adults. In addition, parents prefer non-drug treatment options for 
ADHD83, and thus medical treatments for ADHD remain underutilized85. Finally, the 
beneficial effects of currently available drug and behavioral therapies do not persist after 
discontinuation71,138, thus making alternative treatments with benefits that continue long- 
term highly desirable. 
Some new companies make video games designed to treat ADHD, and FDA has 
issued a guidance for therapeutic game designers. Lexington is becoming a hotbed of 
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videogame development137-138. Pfizer and Shire Pharmaceuticals are funding research in 
videogames. Drug companies will head toward drug/device combinations, even though 
they currently seek prescription video games. Companies like CogCubed and Akili are 
developing videogames for approval as FDA regulated devices, but not drug device 
combinations. There is some evidence of efficacy of games, but the efficacy could be 
improved. The ultimate goal is to increase overall treatment efficacy and create the first 
FDA-approved device/drug combination for ADHD treatment. 
To that end, this clinical trial will be conducted as an exploratory study to 
investigate the functional relationship between NICHQ scores, game aspects of Minecraft, 
and executive function. Two study groups will be included: a videogame group (ADHD 
drug regimen + Minecraft a minimum of 30 minutes per day, 5 times per week x 4 weeks) 
and a control group (ADHD drug regimen only x 4 weeks). By using a no Minecraft control 
group who will continue their usual ADHD medication regimen, we expect to be able to 
determine the effect on executive function from adding Minecraft to the usual standard of 
care for ADHD. (All subjects enrolled in the study will be free to play any video games or 
computer games that they want to play during the course of the study. However, the 
Minecraft group will be the only group of subjects playing in the private Minecraft Realm 
and doing the activities described there.) Furthermore, subjects in the control group will be 
taking varying doses of stimulant medications as well as different types of stimulant 
medications prior to enrolling in the study. This will allow for easier recruitment and, more 
importantly, allow for additional data to be collected. A dose response effect across dose 
parameters will be examined, and the introduced variance will be managed with factor 
analysis139. However, one potential problem in this study design is the effects of other 
medications used to treat ADHD (such as atypical antipsychotics or alpha-2 receptor 
agonists) that may have negative effects on cognitive function, and therefore confound the 
results. We expect that such effects will be negated by requiring that the study subjects are 
being treated with a stimulant medication, which would counteract the negative effects of 
these medications on cognitive function. 
Previous studies which found effects of gaming interventions on executive function 
have used study durations ranging from 2-16 weeks, with 2-5 training sessions per week93. 
However, a less intense schedule of 5 x 30 minute (minimum) game sessions per week for 
4 weeks was chosen for this study because of concerns related to lowered compliance to 
study procedures. These concerns are due to the study’s taking place during the school 
year, when increased time demands for the study subjects could limit adherence to a more 
intensive intervention schedule. 
Our hypothesis is that subjects in the videogame group (usual ADHD drug + 
Minecraft) will show improvements in NICHQ scores and executive function at the end of 
the 4 week game playing period compared to the control group. 
Pharmaceutical therapy is the most effective monotherapy for most patients with 
ADHD, with the exception of the very young89. The advantages of a combining 
pharmaceutical therapy with behavioral therapy include lower cost, as personnel time with 
patients is reduced, and reduced doses of pharmaceutics (50-75%)90. Additionally, the 
benefits of behavior therapy are more likely to carry forward once treatment has stopped90. 
Behavior therapy for ADHD patients includes repetitively reducing negative behaviors 
26 
 
with consequences and increasing positive behaviors with rewards89. One possible 
mechanism of action associated with the effects of Minecraft on ADHD is the opportunity 
for reinforcement of positive behavior and punishment for negative behaviors provided by 
Minecraft. Minecraft is an online medium with several built-in components similar to 
behavior therapy exercises but enjoyable so that children are likely to want to play. High 
performance in several major executive functions noted to be lacking in autistic children is 
positively reinforced by gameplay, in that success yields completion of a specific task, 
acquisition of a rare in-game item, or even character survival in a given situation. 
Furthermore, Minecraft allows players to re-attempt failed challenges as characters re-
spawn after death, though with certain disadvantages. This both gives players the impetus 
to improve in those executive functions (to prevent character death or hassle) and the ability 
to continue improving. 
 
Application of executive functions in gameplay is exemplified in the following: 
1) Executive Functions Exemplified in Construction - A great deal of time and 
focus are required to acquire the necessary resources and build a desired project, 
particularly in Survival mode (a mode of gameplay which requires players to 
harvest resources while harassed by cartoon monsters); a great amount of time and 
self-direction are required to build an ideal structure in Creative mode as well (a 
mode of gameplay in which players have free, unlimited access to all resources, 
unlimited mobility, and no danger of character death). The construction of complex 
structures requires inhibition as players must work exclusively on one project to 
complete it in a timely fashion, working memory as players must mentally construct 
the project in their minds in order to place building blocks on the proper squares of 
the game grid, planning as players choose how much of the resources they wish to 
acquire and design their structures, and self-monitoring as players balance their 
time and the amount of risk associated with the acquisition of resources. 
2) Executive Function Exemplified in Mobility - Manual dexterity is required for 
proper placement of blocks, navigation of obstacles, and combat with cartoon 
monsters. All of these can be difficult, and the failure to execute these maneuvers 
correctly results in character death (and loss of experience and items) and/or in the 
frustration of traveling back to the location, often over difficult terrain. 
3) Executive Function Exemplified in Fluidity - Maintaining and changing mental 
set and emotional regulation is applicable to overcoming challenges presented in 
survival mode in particular, though challenges also arise in the building process in 
any mode, and players often have to modify their strategies in order to succeed. 
4) Executive Function Exemplified in General Gameplay - Focus and concentration 
skills are practiced as players must monitor their health and surroundings in the 
game to stay alive. Due to the fact that Minecraft is borderless, subjects can become 
lost if attention is not paid to their surroundings. While other games may also 
require monitoring of health, there is an element of required organizational skills 
that may be missing in other video games popular with this demographic. While 
subjects will likely have an exhaustive inventory of general supplies after having 
played for awhile, survival may mean the ability to find needed supplies quickly 
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and acquisition of specialized resources is still a lengthy and sometimes difficult 
process (when play is conducted in Survival mode). 
 
In contrast to the behavioral training components of Minecraft, the training of 
executive function is expected to yield more generalizable benefits across multiple 
environments, because executive function processes underlie all cognitive processes while 
training to modify behaviors can only affect the specific behaviors targeted69. Moreover, 
training of working memory has previously been shown to increase cortical D1 receptor 
density91. As dopaminergic function is compromised in ADHD92, these alterations could 
provide additional benefits in improving the function of patients with ADHD. In order to 
direct the practice of these executive functions, during this trial players will be required to 
work from an activity list with additional reinforcement for practicing behavior therapy 
type activities. A self-assessment component of the trial will encourage subjects to develop 
self-cognition, or metacognition. 
In addition to its effects on behavior and executive function, Minecraft could 
beneficially affect neurological functions underlying cognitive control. A previous study 
assessing the effects of a therapeutic video game designed to train multitasking ability in 
elderly subjects found that improvements in multitasking were associated with increases in 
midline frontal theta power and long-range theta coherence between the frontal and 
posterior brain regions as determined by two electroencephalography methods used to 
assess cognitive control. These improvements persisted for six months following the 
completion of training and reached a level comparable to that of younger adults102. 
Furthermore, utilizing cognitive training activities in a gaming format is suggested 
to increase motivation and one’s ability to learn98. This effect is thought to be mediated by 
games producing increased striatal dopamine levels99-100 that enhance long-term 
potentiation of neural connections in the striatum101,140. 
3.1.3 Potential Risks and Benefits 
3.1.3.1 Known Potential Risks of Video Games, Specifically Minecraft 
The immediate risks of this study appear to be few. Although there is little research 
on the effect of Minecraft in humans, there is considerable research on the effects of other 
video games. Like pharmaceuticals, the effect seen seems to be often related to the amount 
and style of video games to which humans are exposed. One person shooter games with 
violence are associated with anxiety141. The negative outcomes of video play include 
obesity142, aggressiveness143, and addiction144. The risk of obesity is complicated by some 
studies that suggest high school students who exceeded the recommended screen time (TV 
and computers) were also more likely to consume fast food and sugary drinks and less 
likely to consume fruits and vegetables145. Additional potential risk might include eye 
strain146, repetitive motion injuries147, seizures148, and vertigo/motion sickness149. 
Diagnosis rates of ADHD in children range from 5-11% compared to 2.5% in 
adults80-82. Diagnosis of ADHD rose 42% from 2003–2004 to 2011–201281. In 2011, 3.5 
million children were being treated with therapeutics as reported by their parents81. 
Unfortunately, increased availability of stimulants tends to increase nonmedical use of 
amphetamine-type ADHD drugs by adolescents and young adults. An estimated 97% of 
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adolescents play video games150. On average, American children play video games at least 
one hour per day151. Additional nonpharmaceutical therapies are needed for ADHD 
because stimulant diversion is associated with increased availability of amphetamines. The 
prevalence of ADHD along with the total amount of time American children spend playing 
video games would provide a rationale for the study of both. 
The video game chosen, Minecraft, is considered to be nonviolent. One of the only 
violent aspects is cartoon skeletons that have the ability to shoot arrows. Thus, care has 
been taken to select a nonviolent game. Secondly, time spent playing Minecraft was limited 
to 30 minutes/day, far less than the normal amount of time most American children spend 
playing video games. Risks have also been minimized with purchase of private Minecraft 
Realms for the participants. Children playing Minecraft during the trial will only interact 
with investigators and other subjects while playing and their play will be monitored 
periodically by investigators to ensure appropriate play by all. 
3.1.3.2 Known Potential Risks of Video Games with CNS Stimulant Treatment 
Little is known about potential risks of videogame play with a background of CNS 
stimulant treatment. Sudden death has been reported in association with CNS stimulant 
treatment alone at usual doses in children and adolescents with structural cardiac 
abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious 
cardiac problems that may predispose increased vulnerability to the sympathomimetic 
effects of a stimulant drug. 
Administration of stimulants may exacerbate symptoms of behavior disturbance 
and thought disorder in patients with pre-existing psychotic disorder. Particular care should 
be taken in using stimulants to treat ADHD patients with comorbid bipolar disorder 
because of concern for possible induction of mixed/manic episode in such patients. 
Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional 
thinking, or mania in children and adolescents without prior history of psychotic illness or 
mania can be caused by stimulants at usual doses. 
Other adverse effects of amphetamines include growth suppression, loss of 
appetite, weight loss, stomach ache, insomnia, headache, rebound symptoms, and 
irritability/jitteriness66. 
3.1.3.3 Known Potential Benefits of Video Games 
Action video games are associated with increased multiple tracking tasks 
(improved attention)152, increased basic cognitive skills such as tracking objects moving at 
greater speeds, better ability to detect changes to objects stored in visual short-term 
memory, to change tasks more rapidly, and mentally rotate objects more efficiently153. 
3.2 Objectives and Purpose 
3.2.1 Primary Objective 
To derive a functional154 relationship between NICHQ scores, game aspects of 
Minecraft, and executive function. 
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3.2.2 Secondary Objectives 
Using EDA and factor analysis, we will examine specific clinical symptoms of 
ADHD, including deficits in inhibition, working memory, planning, self-monitoring, 
verbal regulation, motor control, maintaining and changing mental set and emotional 
regulation as revealed by the NICHQ questionnaire and other assessments, that are affected 
by putative therapeutic features of the game Minecraft to determine which features to 
enhance to increase effectiveness of the intervention. 
3.3 Study Design and Endpoints 
3.3.1 Description of the Study Design 
This clinical trial will be conducted as an exploratory, randomized parallel open 
label pilot study to investigate the functional relationship between NICHQ scores, game 
aspects of Minecraft, and executive function in ADHD patients receiving stimulant type 
medications as standard of care. 
The study has two arms and is conducted at a single center using multiple 
physicians. The study agent/intervention is the video game Minecraft. Subjects will be 
randomized by sex and age to the video game group or the combination group. The two 
study groups include a study group (ADHD drug regimen + Minecraft played for a 
minimum of 30 minutes per day, 5 times per week for 4 weeks) and a control group (ADHD 
drug regimen only followed for 4 weeks). There are no schedule changes, stratifications, 
or dose escalations. 
3.3.2 Study Endpoints 
3.3.2.1  Primary Endpoint 
The primary endpoint of this pilot study will be change in ADHD symptoms as 
measured by the NICHQ questionnaire after 4 weeks of therapeutic gaming. No statistical 
hypothesis is being tested. Post hoc exploratory data analysis (EDA) techniques will be 
applied to compare drugs used and their doses along with game features to the NICHQ 
results. 
3.3.2.2  Secondary Endpoint 
Using EDA and factor analysis, we will examine specific clinical symptoms of 
ADHD, including deficits in inhibition, working memory, planning, self-monitoring, 
verbal regulation, motor control, maintaining and changing mental set and emotional 
regulation as revealed by the NICHQ questionnaire and other assessments, that are affected 
by putative therapeutic features of the game Minecraft to determine which features to 
enhance to increase effectiveness of the intervention. 
3.3.2.3 Exploratory Endpoints 
Not Applicable.
 
 
3.4 Study Enrollment and Withdrawal 
3.4.1 Participant Inclusion Criteria 
In order to be eligible to participate in this study, an individual must meet all of the 
following criteria: 
1. Primary diagnosis of ADHD in accordance with DSM-5. 
2. On a current regimen of a stimulant type ADHD medication, such as Vyvanse. 
3. Sex: males and females. 
4. Age: between 10 and 15 years of age. 
5. Stated willingness to comply with all study procedures and availability for the 
duration of the study, including adherence to medication and play regimen. 
6. Are capable, as determined by the investigator, to perform the following: 
a. complete the study log. 
b. are able to comply with the required study visits. 
7. Have given written informed assent along with parents/legal guardians to 
participate in this study in accordance to local regulations before any trial related activities 
(other than initial screening) are carried out. 
8. Are Minecraft players and have access to a full version of PC/Mac (Java) 
Minecraft, Xbox Minecraft, or pocket Minecraft version (Android, Kindle) that supports 
play on Realms. 
9. Subjects’ parents and subjects both currently have Google accounts and 
electronic devices to access Google accounts online. 
10. Must have an NICHQ Vanderbilt Assessment scored by parents and teacher(s) 
within the last month, or get an assessment scored by parents and teacher(s) within one 
week of enrollment and before beginning to play the video game if the subject is in the 
video game arm). 
11. At least one parent and the subject must be proficient in spoken and written 
English. 
.
3.4.2 Participant Exclusion Criteria 
Any of the following would render a person ineligible to participate in the study: 
1. Current or past history of substance abuse. 
2. Patients who for whatever reason are deemed by the investigator inadequate for 
participation in this trial (e.g., patients with incapacitating mental illness). 
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3. Have previously completed or withdrawn from this study after having signed the 
informed consent/assent document. 
4. Lack of proficiency in spoken and written English 
3.4.3 Strategies for Recruitment and Retention 
As the study is a pediatric study, the pediatric population is the only one being 
studied. ADHD disproportionately affects children and therefore, children are the subjects 
being recruited. Recruitment will include females and minority groups as appropriate. The 
ADHD population is predominantly male, so our study population will reflect the patient 
population. The medical investigators contacted for this trial have indicated they 
predominantly treat Medicaid patients, thus lower economic status patients should also be 
adequately represented. 
Compensation ($100/subject) will be provided to children and parents in a 60/40 
split to compensate for their playing time, travel time, and expenses to the site. Children 
will be given $60 gift cards for participation and one parent/legal guardian will be paid $40 
via check. 
As the study duration is only 4 weeks, study retention is not likely to be a problem. 
Additionally, study personnel will contact subjects periodically if subjects do not appear to 
be logging on and playing Minecraft or if data is not being shared with researchers. Subjects 
will be asked to unshare their data with us after the trial has been completed. 
UK CCTS will be the only clinical site. Thirty-two patients (32) will be screened 
in order to enroll 16 subjects (8 female 8 male), to ensure 12 complete the study. The study 
will enroll 16 participants (8 female, 8 male) with a previous medically confirmed 
diagnosis of ADHD at the CCTS in order to have at least 12 complete the study. All of the 
16 subjects enrolled will currently be on a stimulant type ADHD drug regimen with active 
prescriptions. 
An i2b2 survey conducted in July 2016 identified 257 potential subjects which are 
currently on a standard of care including a stimulant type ADHD drug. It is expected that 
all investigators will go through their medical files and will review existing patient records 
to screen these patients for inclusion and exclusion criteria. Similarly, additional study 
candidates will be referred by other physicians or will respond to advertisements or web 
announcements made by CCTS if recruitment falls short of goals. 
3.4.4 Participant Withdrawal or Termination 
3.4.4.1 Reasons for Withdrawal or Termination 
Participants are free to withdraw from participation in the study at any time upon request. 
An investigator may terminate participation in the study if: 
Any clinical adverse event (AE), laboratory abnormality, or other medical 
condition or situation occurs such that continued participation in the study would 
not be in the best interest of the participant 
The participant meets an exclusion criterion (either newly developed or not 
previously recognized) that precludes further study participation. 
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3.4.4.2 Handling of Participant Withdrawals or Termination 
In case any participant drops-out from the study at any given point during the study 
period, every effort will be made to contact the subject by phone, mail, and email to 
investigate the reason for the subject stopping participation in the trial. Should a subject 
decide to withdraw, all efforts will be made to complete and report the observations as 
thoroughly as possible and collect study products (NICHQ assessments, Minecraft Realms, 
self-assessments). Additional subjects initially screened but not enrolled may be added if 
the investigators feel this is warranted. 
3.4.5 Premature Termination or Suspension of Study 
This study may be temporarily suspended or prematurely terminated if there is 
sufficient reasonable cause. Written notification documenting the reason for study 
suspension or termination will be provided by the suspending or terminating party to the 
Investigator, funding agency, and regulatory authorities. If the study is prematurely 
terminated or suspended, the PI will promptly inform the IRB and will provide the 
reason(s) for the termination or suspension. 
 
Circumstances that may warrant termination or suspension include, but are not limited to: 
Determination of unexpected, significant, or unacceptable risk to participants 
Demonstration of efficacy that would warrant stopping 
Insufficient compliance to protocol requirements 
Data that are not sufficiently complete and/or evaluable 
Determination of futility 
 
The study may resume once concerns about safety, protocol compliance, data quality are 
addressed and satisfy the sponsor and IRB. 
3.5 Study Agent 
3.5.1 Study Agents(s) and Control Description 
3.5.1.1  Acquisition 
The study agent in this study is the video game Minecraft. The subjects will already 
be Minecraft players and will already have Gmail accounts. The subjects will receive 
instructions for Minecraft play via their Google Mail accounts. Study subjects will already 
be on a regimen of prescription drugs as standard of care from their physicians. 
3.5.1.2 Formulation, Appearance, Packaging and Labeling 
The Minecraft game is available for download on the Internet and has no packaging, 
labeling or appearance. 
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Minecraft Study participants in this protocol will already be on a regimen of various 
FDA approved stimulant-type ADHD medication therapies in various doses. Those drugs 
are standard of care agents and it is not practical to discuss the formulation, appearance, 
packaging or labeling of all the different types of possible pharmaceuticals. 
3.5.1.3 Product Storage and Stability 
Minecraft can be stored on a hard drive or removable media (such as a USB 
memory stick). Downloaded Realm worlds will be saved with a user’s single player worlds. 
Downloaded worlds are accessible offline and are available for upload to another Realm 
or world on your Realm. 
3.5.1.4 Preparation 
Subjects will be asked to play the desktop computer version of Minecraft. 
3.5.1.5 Dosing and Administration 
Subjects will be asked to play Minecraft for a minimum of 30 minutes per day five 
times per week. 
3.5.1.6 Route of Administration 
Not applicable. 
3.5.1.7 Starting Dose and Dose Escalation Schedule 
Subjects will be asked to play Minecraft for a minimum of 30 minutes per day five 
times per week. There will be no escalation. 
Subjects will maintain their prescribed doses of ADHD medication that were 
determined by their physician prior to enrollment in the study. 
3.5.1.8 Dose Adjustments/Modifications/Delays 
Not applicable. 
3.5.1.9 Duration of Therapy 
The videogame trial is scheduled to last for four weeks. Subjects will maintain 
current standard of care during and after the trial. 
3.5.1.10 Tracking of Dose 
Subjects will log their own video game play on their existing online accounts. 
Parents will track children’s medication compliance on their existing online 
accounts. They will be asked to share the data periodically with investigators. 
3.5.1.11 Device Specific Considerations 
Not applicable. 
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3.6 Study Procedures and Schedule 
3.6.1 Study Procedures/Evaluations 
3.6.1.1 Study Specific Procedures 
Medical history will be obtained by interview by CCTS. Most recruited individuals 
will be the patients of the initial medical investigators and the investigators will also have 
their patients’ histories. Investigators will be added if recruitment falls short of goals.  
 
Questions to be asked of subjects include: 
1. Do you have any current medical problems or issues other than ADHD? 
2. What illnesses have you been diagnosed with in the past? Age at diagnosis? 
3. What surgeries have you had in the last five years? 
4. How often do you normally play computer and video games? What hardware 
platforms do you use (desktop, pad, phone, console?) How long is an average 
session of playing on each? What video games have you previously played on each? 
What are the dates you played these games (i.e., approximately when did you start, 
and if you no longer play, when did you stop?) 
 
Medicinal history will be obtained by interview. CCTS personnel will use this 
information to ascertain whether subjects are eligible for enrollment as all participants are 
required to be currently taking a stimulant type ADHD medication.  
 
Questions will include: 
1. What prescription medications are you taking for ADHD? What are the doses 
and schedule? 
2. What prescription medications are you taking for other indications? What are the 
doses and schedule? 
3. What OTC medications, or herbal supplements are you currently taking? What 
are the doses? How often do you take them? 
 
Physical examination will include height and weight at both exams. 
 
Discussion Points: 
1. No results will be shared with trial subjects. 
2. Assessment of study agent adherence 
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3. Administration of questionnaires or other instruments for subject-reported 
outcomes, such as the NICHQ, self-assessment questions, parent reported study 
compliance for medications, video gaming log, and completed activity list. 
3.6.1.2 Standard of care study procedures 
A Psychiatrist will serve as the medical director and a site PI. The PI as well as the 
other physicians (Medical Investigators) are responsible for standard of care and NICHQ 
assessments from parents and teachers. 
Standard of care for children 6-11 years of age is FDA-approved medications for 
ADHD and/or evidence based parent and or teacher-administered behavior therapy as 
treatment, preferably both89. Stimulant based medication is strongly recommended. 
Adolescents, aged 12-18, should be administered FDA-approved ADHD medication with 
the patient’s accent. Behavior therapy may also be added to the prescription regimen. The 
dose of the medication should be titrated to achieve the maximum benefit of the drug with 
the fewest side effects. 
3.6.2 Laboratory Procedures/Evaluations 
3.6.2.1 Clinical Laboratory Evaluations 
Not applicable. 
3.6.2.2 Other Assays of Procedures 
Not applicable. 
3.6.2.3 Specimen Preparation, Handling, and Storage 
Not applicable. 
3.6.2.4 Specimen Shipments 
Not applicable. 
3.6.3 Study Schedule 
3.6.3.1 Screening 
This is a rolling enrollment trial. Enrollment is expected to be open for a maximum 
of 62 days. Final visit will occur within 7 days of completing 42 days of video therapy. 
Prescreening Visit (Day 0 to 60) 
• Obtain informed consent/assent of potential participant verified by 
signature on written informed consent for screening form. 
• Review medical history to determine eligibility based on 
inclusion/exclusion criteria. 
• Review medications history to determine eligibility based on 
inclusion/exclusion criteria. 
• Review history of computer and video game play (which games, start date, 
end date, minutes per day 
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Figure 5 - Therapeutic Video Games Pilot Study Timeline 
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Prescreening Visit (Day 0 to 60, cont.) 
• Perform medical examinations needed to determine eligibility based on 
inclusion/exclusion criteria. 
• Provide participants with instructions, such as, we will evaluate your tests 
and contact you within 4 weeks to tell you whether you have been chosen 
to participate in the study. Do not do anything regarding this trial until we 
contact you. If you are chosen you should follow the instructions in the 
subject instructions (hand potential subjects’ and parents a copy of these 
instructions). Review important parts of the trial protocol in the instructions 
including the difference in the trial groups, the IT requirements, and the data 
to which the investigators will expect to be given access. 
3.6.3.2 Enrollment/Baseline 
Enrollment (Day 1-44) 
●  Ascertain that potential participants have NICHQ scores (no older than 1 month 
old) from parents, collected on visit 1, and teachers, submitted by medical 
investigators, before subjects can be enrolled in trial. After eligibility has been 
determined, attempt to enroll eligible subjects, with priority given to 10-12 years 
old, but open up to 15 year olds if 16 subjects are not available in the 10-12 year-
old range, with randomization based upon age and sex.  If for any reason the final 
NICHQ assessments from teachers are not available, the study will simply treat 
them as missing data.  However, the initial assessment must be available for 
enrollment.  Enrollment will be conducted by electronic means ( telephone and/or 
email). 
● Contact eligible participants via phone to reconfirm current eligibility and 
enrollment, provide groups assignment, and review study instructions, including 
continuing with ADHD medication. If potential participants can not be reached 
after 3 phone call or 2 emails, they will be excluded from the study and another 
participant enrolled. Ask subjects to verbally confirm what their activities will be 
during the trial to confirm their understanding.  Gather Google emails addresses 
from parents and children, if available. Determine which version of Minecraft the 
subjects randomized to the Minecraft group will play (i.e. do subject wish to play 
via a PC or a gaming console or mobile device) Details to discuss with participants: 
See phone script. Remind subjects that study instructions will also be shared with 
them via Google Drive.  
● Schedule final study visits for participants who are enrolled in the study. 
 
3.6.3.3 Follow-up 
Not applicable. 
3.6.3.4 Final Study Visit 
Final Study Visit (Visit 2, Day 29-86, including + 7 day window to have final visit after 
last completer of 28 days of video therapy)  
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• Record adverse events as reported by participant or observed by 
investigator. Subjects will be told to report AEs to their physician. 
• Record weight and results of post- NICHQ questionnaire. The post study 
NICHQ data will allow us to assess the primary endpoint, change in NICHQ 
scores. The secondary endpoints can be assess through the electronic data 
made available to the investigative team periodically by the subjects and 
their parents throughout the study.  
• Record participant’s adherence to regimen. 
• Provide final instructions: Continue your standard of care routine from your   
physician.  
• Inform patients and parents that data will not be available to them. Since 
this is  an exploratory study neither efficiency nor safety is being assessed. 
Thus, it is unlikely to present any meaningful information to the subjects.  
It will likely consist of only patterns and be used to guide further research.  
3.6.3.5 Early Termination Visit 
If an early termination visit occurs, all final study visit procedures should be 
performed. 
3.6.3.6 Unscheduled Visit 
Since this trial is only 4 weeks long, it is doubtful that any unexpected visits will 
occur. If an unscheduled visit should occur data concerning AEs will be documented. 
3.6.4 Concomitant Medications, Treatments, and Procedures 
All concomitant prescription medications taken during study participation will be 
recorded on the case report forms (CRFs). For this protocol, a prescription medication is 
defined as a medication that can be prescribed only by a properly authorized/licensed 
clinician. Medications to be reported in the CRF are concomitant prescription medications, 
over-the-counter medications and nonprescription medications. 
3.6.4.1 Precautionary Medications, Treatments, and Procedures 
Not applicable. 
3.6.4.2 Prohibited Medications, Treatments, and Procedures 
Not applicable. 
3.6.4.3 Prophylactic Medications, Treatments, and Procedures 
Not applicable. 
3.6.4.4 Rescue Medications, Treatments, and Procedures 
Not applicable. 
3.6.4.5 Participant Access to Study Agent at Study Closure 
Although Minecraft is commercially available to play for free the Minecraft Realms 
used in this study will be closed and not available for additional play by participants. 
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Table 1 - Schedule of Events in Therapeutic Video Games Pilot Study 
Event Visit 1 Screening Enrollment Final Visit 
Registration x   
Schedule Visit (Terminal )  x  
Informed Consent/Assent x   
Medical History x   
Demographics x   
Previous & Concomitant 
Medication interview 
x x x 
Review 
Inclusion/Exclusion criteria 
x x  
Dispense questionnaire 
tests (ADHD assessment) 
x  x 
Education materials-collect 
questionnaires 
x  x 
Randomize participants  x  
CRF enter and Transmit x x x 
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3.7 Assessment of Safety 
3.7.1 Specification of Safety Parameters 
3.7.1.1 Definition of Adverse Events (AE) 
Adverse event means any untoward medical occurrence associated with the use of 
an intervention in humans, whether or not considered intervention-related (21 CFR 312.32 
(a)). 
3.7.1.2 Definition of Serious Adverse Events (SAE) 
An AE or suspected adverse reaction is considered "serious" if, in the view of either 
the investigator or sponsor, it results in any of the following outcomes: death, a life- 
threatening adverse event, inpatient hospitalization or prolongation of existing 
hospitalization, a persistent or significant incapacity or substantial disruption of the ability 
to conduct normal life functions, or a congenital anomaly/birth defect. Important medical 
events that may not result in death, be life-threatening, or require hospitalization may be 
considered serious when, based upon appropriate medical judgment, they may jeopardize 
the patient or subject and may require medical or surgical intervention to prevent one of 
the outcomes listed in this definition. Examples of such medical events include allergic 
bronchospasm requiring intensive treatment in an emergency room or at home, blood 
dyscrasias or convulsions that do not result in inpatient hospitalization, or the development 
of drug dependency or drug abuse. 
3.7.1.3 Definition of Unanticipated Problems (UP) 
OHRP considers unanticipated problems involving risks to participants or others to 
include, in general, any incident, experience, or outcome that meets all of the following 
criteria: 
Unexpected in terms of nature, severity, or frequency given (a) the research 
procedures that are described in the protocol-related documents, such as the IRB-
approved research protocol and informed consent document; and (b) the 
characteristics of the participant population being studied; 
Related or possibly related to participation in the research (“possibly related” means 
there is a reasonable possibility that the incident, experience, or outcome may have 
been caused by the procedures involved in the research); and 
Suggests that the research places participants or others at a greater risk of harm 
(including physical, psychological, economic, or social harm) than was previously 
known or recognized. 
This study will use the OHRP definition of UP. 
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3.7.2 Classification of an Adverse Event 
3.7.2.1 Severity of Event 
All AEs will be assessed by the clinician using a protocol defined grading system. 
For this trial, AEs related/not related will be those associated with playing the video game. 
Stimulant related AE’s, which are standard of care, will be reported to Medwatch at 
physician’s discretion. For AEs not included in the protocol defined grading system, the 
following guidelines will be used to describe severity. 
 
Mild – Events require minimal or no treatment and do not interfere with the 
participant’s daily activities. 
Moderate – Events result in a low level of inconvenience or concern with the 
therapeutic measures. Moderate events may cause some interference with 
functioning. 
Severe – Events interrupt a participant’s usual daily activity and may require 
systemic drug therapy or other treatment. Severe events are usually potentially life-
threatening or incapacitating. 
 
3.7.2.2 Relationship to Study Agent 
All AEs will have their relationship to study agent or study participation assessed 
with a level of specificity appropriate to the study design. 
The clinician’s assessment of an AE's relationship to study agent is part of the 
documentation process, but it is not a factor in determining what is or is not reported in the 
study. If there is any doubt as to whether a clinical observation is an AE, the event should 
be reported. All AEs must have their relationship to study agent assessed. In a clinical trial, 
the study product must always be suspect. To help assess, the following guidelines are 
used. 
 
Related – The AE is known to occur with the study agent, there is a reasonable 
possibility that the study agent caused the AE, or there is a temporal relationship  
between the study agent and event. Reasonable possibility means that there is 
evidence to suggest a causal relationship between the study agent and the AE. 
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Not Related – There is not a reasonable possibility that the administration of the 
study agent caused the event, there is no temporal relationship between the study 
agent and event onset, or an alternate etiology has been established. 
 
3.7.2.3 Expectedness 
Expected adverse reactions are AEs that are common and known to occur for the 
study agent being studied and should be collected in a standard, systematic format using a 
grading scale based on functional assessment or magnitude of reaction. An AE or suspected 
adverse reaction is considered "unexpected" if it is not listed in the IB or is not listed at the 
specificity or severity that has been observed; or, if an IB is not required or available, is 
not consistent with the risk information described in the general investigational plan or 
elsewhere in the protocol, as amended. 
Medical Investigators (i.e., the subject’s physician) will be responsible for 
determining whether an AE is expected or unexpected. An AE will be considered 
unexpected if the nature, severity, or frequency of the event is not consistent with the risk 
information previously described for Minecraft. 
3.7.3 Time Period and Frequency for Event Assessment and Follow-up 
The occurrence of an AE or SAE may come to the attention of study personnel 
during study visits and interviews of a study participant presenting for medical care, or 
upon review by a study monitor. All AEs including local and systemic reactions not 
meeting the criteria for SAEs will be captured on the appropriate CRF. Information to be 
collected includes event description, time of onset, clinician’s assessment of severity, 
relationship to study product (assessed only by those with the training and authority to 
make a diagnosis), and time of resolution/stabilization of the event. All AEs occurring 
while on study must be documented appropriately regardless of relationship. All AEs will 
be followed to adequate resolution. 
Any medical condition that is present at the time that the participant is screened 
will be considered as baseline and not reported as an AE. However, if the study 
participant’s condition deteriorates at any time during the study, it will be recorded as an 
AE. UPs will be recorded in the data collection system throughout the study. 
Changes in the severity of an AE will be documented to allow an assessment of the 
duration of the event at each level of severity to be performed. AEs characterized as 
intermittent require documentation of onset and duration of each episode. 
The PI will record all reportable events with start dates occurring any time after 
informed consent is obtained until 7 (for non-serious AEs) or 30 days (for SAEs) after the 
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last day of study participation. At the study visit, the investigator will inquire about the 
occurrence of AE/SAEs since the initial visit. Events will be followed for outcome 
information until resolution or stabilization. 
3.7.4 Reporting Procedures 
3.7.4.1 Adverse Event Reporting 
Responsible Parties 
Sponsor/Investigator/ Safety Officer- Robert Lodder 
Other Investigators - Medical Investigators (site PIs), Adriane Grumbein, and Kyra 
Hunting 
The Sponsor-Investigator/Safety Officer will inform the IRB of any events of which he 
becomes aware of. 
3.7.4.2 Serious Adverse Event Reporting 
Safety reports will be made of potential serious risks, from clinical trials or any 
other source, as soon as possible, but in no case later than 14 calendar days after the sponsor 
determines that the information qualifies for reporting. 
The PI will report any suspected adverse reaction that is both serious and 
unexpected. The sponsor must report an adverse event as a suspected adverse reaction only 
if there is evidence to suggest a causal relationship between the therapeutic agent and the 
adverse event, such as: 
(A) A single occurrence of an event that is uncommon and known to be strongly 
associated with drug exposure (e.g., angioedema, hepatic injury, Stevens-Johnson 
Syndrome); 
(B) One or more occurrences of an event that is not commonly associated with drug 
exposure, but is otherwise uncommon in the population exposed to the drug (e.g., tendon 
rupture); 
(C) An aggregate analysis of specific events observed in a clinical trial (such as 
known consequences of the underlying disease or condition under investigation or other 
events that commonly occur in the study population independent of drug therapy) that 
indicates those events occur more frequently in the drug treatment group than in a 
concurrent or historical. 
Life-threatening suspected adverse reaction as soon as possible but in no case later 
than 7 days after sponsor determines that the information. 
The study clinician will complete a SAE Form within the following timelines: 
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Figure 6 - Adverse Events Reporting in Therapeutic Video Games Pilot Study 
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All deaths and immediately life-threatening events, whether related or unrelated, 
will be recorded on the SAE Form and submitted to the study sponsor within 24 hours of 
site awareness.  
Other SAEs regardless of relationship, will be submitted to the study sponsor within 
24 hours of site awareness. 
All SAEs will be followed until satisfactory resolution or until the site investigator 
deems the event to be chronic or the adherence to be stable. Other supporting 
documentation of the event may be requested by the study sponsor and should be provided 
as soon as possible. 
The study sponsor will be responsible for notifying IRB of any unexpected fatal or 
life- threatening suspected adverse reaction as soon as possible but in no case later than 7 
calendar days after the sponsor's initial receipt of the information. 
 
3.7.4.3 Unanticipated Problem Reporting 
Incidents or events that meet the OHRP criteria for UPs require the creation and 
completion of an UP report form. It is the site investigator’s responsibility to report UPs to 
their IRB. The UP report will include the following information: 
Protocol identifying information: protocol title and number, PI’s name, and the IRB 
project number; 
A detailed description of the event, incident, experience, or outcome; 
An explanation of the basis for determining that the event, incident, experience, or 
outcome represents an UP; 
A description of any changes to the protocol or other corrective actions that have 
been taken or are proposed in response to the UP. 
 
To satisfy the requirement for prompt reporting, UPs will be reported using the 
following timeline: 
UPs that are SAEs will be reported to the IRB within 7 days of the investigator and 
to the sponsor within 24 hours of the investigator becoming aware of the event. 
Any other UP will be reported to the IRB and to the study sponsor within 14 days 
of the investigator becoming aware of the problem. 
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All UPs should be reported to appropriate institutional officials (as required by UK 
per Serious or Continuing Noncompliance or Unanticipated Problems Involving Risks:IRB 
Reporting to Federal Agencies using the UK IRB reporting form within the timeline in 
accordance with the SOP for Unanticipated/Anticipated Problem/Adverse Event Reporting 
(UK) of the IRB’s receipt of the report of the problem from the investigator. 
3.7.4.4 Events of Special Interest 
Not applicable. 
 
3.7.4.5 Reporting of Pregnancy 
Report as a non-treatment related AE to the IRB. Physicians will ultimately make 
the decision as to whether to continue the drugs they have prescribed. If subjects are 
removed from their ADHD pharmaceutical regimen then participants will be discontinued 
from study. Subjects that remain on the ADHD pharmaceutical regimen will continue in 
the study. 
3.7.5 Study Halting Rules 
Administration of study agent will be halted when three severe AEs determined to 
be “probably related” are reported to the Study Coordinator. The Study Coordinator will 
notify the study sponsor and investigators immediately when the third severe event is 
reported and enrollment screens will stop accepting new study participants. The study 
sponsor will inform the IRB within 24 hours of this occurrence and will provide the IRB 
with AE listing reports. The Investigative team, medical investigators, and CCTS will 
convene an ad hoc meeting by teleconference or in writing as soon as possible. 
3.7.6 Safety Oversight 
As overall risk of this study is extremely low due to use of subjects’ normal standard 
of care FDA approved pharmaceutical and a non-rated, fairly innocuous video game (No 
language concerns, limited violence (i.e. cartoon skeletons shooting arrows and scary cave 
noises), as well as portals to the Nether). Therefore, a data safety management board will 
not be used. Safety oversight will be under the direction of the Monitor, with prior expertise 
in clinical monitoring. The Monitor will inspect the CCTS site at least once to assess data 
in the study. The Study Monitor will provide its input to the study sponsor. 
3.8 Clinical Monitoring 
Our designated monitor will conduct the monitoring. The monitor has experience 
monitoring other human trials. Monitoring will include an on-site initiation visit and close 
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down visit. Additional remote monitoring will be conducted to verify data by our auditor. 
Data verification will be comprehensive (100%) of the primary endpoint. Secondary 
endpoint verification of data will be more random with at least 10% of data verified. The 
monitor will also distribute monitoring reports to the Sponsor/Investigator and our research 
coordinator at CCTS. 
Independent audits will not be conducted to ensure monitoring practices are 
performed consistently across all participating sites. 
CCTS will perform internal quality management of study conduct, data collection, 
documentation and completion. An individualized quality management plan will be 
developed to describe the site’s quality management. 
3.9 Statistical Considerations 
3.9.1 Statistical and Analytical Plans 
This is a pilot study to investigate video game use as an add-on to stimulant type 
ADHD medications. 
3.9.2 Statistical Hypotheses 
None. This is an exploratory data analysis to look for relationships between game 
design factors and NICHQ scores and executive functions. 
3.9.3 Analysis Datasets 
Safety Population - All subjects who play at least one day on the trial Minecraft 
realm will be included in the safety analyses. All adverse events reported in this study will 
be listed and tabulated using descriptive statistics, frequencies, and proportions. 
Intent-to-Treat (ITT) Analysis Dataset will include all randomized subjects. 
Per-Protocol (PP) Analysis Dataset: All subjects with a pre- and post-trial NICHQ 
questionnaire scores and completed at least 80% of each of the components of the study. 
3.9.4 Description of Statistical Methods 
3.9.4.1 General Approach 
This is a pilot study with a parallel design in which one group plays Minecraft and 
the other group does not. Both groups will already be receiving the ADHD standard of care 
stimulant drugs. No preliminary data are available and there are no expectations regarding 
the results. This pilot study will enable us to propose further studies with testable statistical 
hypotheses. 
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Exploratory data analysis (EDA) techniques will be used for analysis. EDA is an 
approach to analyzing data sets to summarize their main characteristics, often with visual 
methods. A statistical model may or may not be used, because the purpose of EDA is 
primarily to see what the data can tell us beyond a formal modeling or hypothesis testing 
task. Typical EDA modeling techniques include: box plot, histogram, Multi-vari chart, run 
chart, pareto chart, scatter plot, stem-and-leaf plot, parallel coordinates, odds ratio, 
multidimensional scaling, targeted projection pursuit, principal component analysis (PCA), 
multilinear PCA, projection methods such as grand tour, guided tour, and manual tour, 
interactive versions of the plots, single linkage cluster analysis, and other forms of 
hierarchical clustering methods. Quantitative techniques that may be applied include 
median polish, trimean, and ordination to distinguish related patterns. Post hoc tests of 
significance may be performed. In addition, exploratory data analysis enables checks of 
assumptions (e.g., normality) underlying statistical procedures. 
3.9.4.2 Analysis of the Primary Efficacy Endpoint(s) 
For the primary endpoint, due to the small sample size and the fact that this is a 
pilot study, exploratory data analysis will be used. Data to be collected includes pre-play 
and post-play NICHQ questionnaire scores, drugs and doses, and executive functions 
played out in Minecraft. We will be looking for correlation trends and goodness of fit of 
linear and nonlinear models as well as the presence of covariates and factors in the 
predictive model for NICHQ scores. 
All attempts will be made to prevent any missing values. Data imputation may be 
done as part of EDA. For the analysis of the primary endpoint (NICHQ values), the Last 
Observation Carried Forward (LOCF) concept will be used for subjects who discontinue 
prematurely from the study. These results will be compared with those obtained by the use 
of data splines. If for any reason the final NICHQ assessments from teachers are not 
available, the study will simply treat them as missing data and continue with only the 
assessments from the parents. 
Data points that appear to be erroneous or inexplicable based on clinical judgment 
will be investigated and considered outliers. If a data point is identified as an outlier, two 
analyses will be performed, one with the outlier data point and one without the outlier. All 
data points will be reported in the listings, including any data point that may have been 
identified as an outlier. No data points will be excluded from the listings. 
3.9.4.3 Analysis of the Secondary Endpoint(s) 
Secondary Endpoint exploratory data analysis will include subject reflection data, 
number of Minecraft assigned activities completed, subject-reported compliance rate of 
game play and pharmaceutical use, Minecraft Realm history, sex, age, and drugs and dose 
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levels as the factors of interest. For missing data, models will be built with and without 
data imputation and the results compared . 
3.9.4.4 Safety Analyses 
All subjects who play at least one day in the trial Minecraft realm will be included 
in the safety analyses. All adverse events reported in this study will be listed and tabulated 
using descriptive statistics, frequencies, and proportions. 
Safety data will be analyzed for all subjects in the safety population. The safety 
population is defined as all subjects who have signed the study Informed Assent Document 
and have played at least one day in the Minecraft Realm. The safety variables that will be 
analyzed, at the minimum, include all reported adverse events. 
All adverse events (AEs) as defined by the Common Terminology Criteria for 
Adverse Events155 (CTCAE) will be analyzed for safety and tolerability. All study 
emergent adverse events (TEAEs) will be coded using the latest version of the MedDRA 
dictionary. 
The number and proportion of subjects who report any TEAE will be tabulated by 
study group. All reported TEAEs will be summarized using descriptive statistics (n, mean, 
median, range, SD, or number and percentage of subjects) per study group. Study- 
emergent adverse events are defined as those events occurring or worsening upon or after 
receiving the first exposure to the randomized study agent (Minecraft). Adverse events will 
be listed by study group and subject. For any inferential statistics, appropriate statistical 
tests [Chi-square or Fisher’s exact tests for categorical variables and Analysis of Variance 
(ANOVA) or Analysis of Covariance (ANCOVA) with the baseline value as the covariate 
for continuous variables] will be used. These models along with their parameters will be 
detailed in the SAP. 
The Intent-to-Treat (ITT) population, safety population, and efficacy evaluable 
population will be defined and described in detail as part of the Statistical Analysis Plan 
(SAP). The SAP will be developed and finalized before the database is locked. This is a 
pilot study of a videogame and it is not clear what kind of safety information will be 
collected if any during the course of the trial. Information gathered during the interim 
analysis may help in the design of the SAP. 
3.9.4.5 Adherence and Retention Analyses 
Minecraft Realms provides user statistics to allow some subject adherence analysis. 
Additionally, users will be required to provide some user completion data of Minecraft 
associated activities. All subjects will keep a log of video gaming play (all games, including 
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Minecraft). The log will include dates, times, and specific video games played, which will 
be analyzed for adherence and possible confounders. 
3.9.4.6 Baseline Descriptive Statistics 
Baseline demographic data will include age, sex, and race Baseline intervention 
data will include NICHQ pre-study questionnaire scores, gaming history, and medical and 
drug history. 
3.9.4.7 Planned Interim Analyses 
An interim analysis will be conducted by the PI two weeks after the study begins 
to ensure the software is working properly and that all relevant data are being collected in 
the CRF. Conducting an interim analysis will allow investigators to determine any issues 
associated with subjects’ use of technology and/or missing data and resolve these issues 
before database lock. There is no risk in conducting an interim analysis because the study 
is not blinded 
3.9.4.8 Additional Sub-Group Analyses 
Both the primary and secondary endpoints will be analyzed based on age, sex, and 
race. 
3.9.4.9 Multiple Comparison/Multiplicity 
Not applicable. 
3.9.4.10 Tabulation of Individual Response Data 
Individual participant data will be listed by measure and time point. 
3.9.4.11 Exploratory Analyses 
Exploratory analysis will be performed on the NICHQ scores, including: 
Self-reflective scores, video gaming logs, drug use, and Minecraft Realm play by 
subjects digitally saved during the trial will be analyzed post hoc. Exploratory data analysis 
(EDA) is an approach to analyzing data sets to summarize their main characteristics, often 
with visual methods. A statistical model may or may not be used, because the purpose of 
EDA is primarily to see what the data can tell us beyond a formal modeling or hypothesis 
testing task. EDA will be conducted to identify outliers, trends and patterns in data that 
merit further study. 
Types of exploratory procedure will include: box plot, histogram, multi-vari chart, 
run chart, pareto chart, scatter plot, stem-and-leaf plot, parallel coordinates, odds ratio, 
multidimensional scaling, targeted projection pursuit, principal component analysis, 
principal curve analysis, multilinear PCA, projection methods such as grand tour, guided 
tour and manual tour, interactive versions of these plots, single linkage cluster analysis, or 
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other hierarchical clustering methods. Typical quantitative techniques that may be used 
include median polish, trimean, and ordination. 
3.9.5 Sample Size 
The study will enroll 16 subjects (8 female, 8 male) at the UK Center for Clinical 
and Translational Science (CCTS) with a previous medically confirmed diagnosis of 
ADHD in order to have at least 12 complete the study. As this study is primarily 
exploratory, no sample size calculations were performed. Having 6 subjects per group 
allows a standard deviation to be calculated as well as a mean for each group, and also 
minimizes the number of subjects exposed to the intervention in this preliminary pilot 
study. 
If a participant is lost to follow-up at any point during the trial the subject outcome 
will be assessed in the intent to treat analysis under the principle of the last observation 
carried forward (LOCF). 
Statistical software used will include R and Matlab. 
3.9.6 Measures to Minimize Bias 
3.9.6.1 Enrollment/Randomization/Masking Procedures 
The population of subjects with ADHD is predominantly male. The enrollment of 
sexes between the two study arms will be equalized as much as possible. The enrollment 
of different races and ages will also be equalized between the two arms as much as possible 
within the constraints of the small sample size. Participants who discontinue early will not 
be replaced. 
The exploratory pilot study is open label and blinding procedures will not be 
employed. 
3.9.6.2 Evaluation of Success of Blinding 
Not applicable. 
3.9.6.3 Breaking the Study Blind/Participant Code 
Not applicable. 
3.10 Source Documents and Access to Source Documents 
Appropriate medical and research records will be kept for this trial for a minimum 
of 6 years. FDA and IRB personnel will be given access to source data as needed. 
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Source Documents and Data 
Participant files included in trial: CRFs, study compliance logs (gaming and 
medication), self reflection questions, pre- and post-study completed NICHQ 
questionnaires, and memoranda. 
Software as a Service Vendor (SaaS) Models156 
This project will use the multi-tenant infrastructure cloud provided by Google. The 
inclusion criteria will limit subjects to those who are already using Google services. The 
security and privacy controls are basically the same for everyone, with a few variations 
such as two factor authentication which can be enabled or disabled by the subjects. (The 
therapeutic video game (TVG) project can only be accessed with two-factor authentication 
on, but individual subjects have the option of using two-factor authentication or leaving it 
turned off for their own data). 21 CFR part 11 compliance is gained by a business associate 
agreement with Google, by designing our security controls to interface with those specified 
by the agreement with Google, and by following our SOP's (built around 21 CFR part 11 
compliance). Google also employs version control making the trial documents, even those 
completed by subjects, completely traceable. Version control, a standard feature of Google 
Drive, allows researchers to monitor the date, ownership, and exact change made to any 
source document, including assessments. Minecraft Realm administrator privileges also 
allow the research team to access the individual playing time metrics to analyze for 
discrepancies between actual time played versus the self reported playing time. 
Platform as a Service (PaaS) vs. SaaS157 
NIST defines PaaS as the capability provided to the user to deploy onto the cloud 
infrastructure programs created by the user or acquired by the user. Acquired applications 
are created using programming languages, libraries, services, and tools supported by the 
provider. The purpose of PaaS is to provide a programming platform to create a software 
application solution without the overhead of hosting and maintaining the underlying 
technology stack. 
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Figure 7 - Software as a Service (SaaS) Vendor Model 
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Figure 8 - Platform as a Service (Paas) Vs. Software as a Service (Saas) Vendor Model 
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NIST defines SaaS as the capability provided to the user to run the provider’s 
applications executing on a cloud infrastructure. The applications are accessible from 
various client devices through either a thin client interface, such as a web browser, or a 
program interface. The user does not manage or control the underlying cloud infrastructure 
including network, servers, operating systems, storage, or even individual application 
capabilities, with the possible exception of limited user specific application configuration 
settings. 
Using both SaaS and PaaS enables the encryption of subject-provided data from a 
SaaS system in a PaaS system (the Therapeutic Video Games or TVG Google PaaS). 
Data stored will be encrypted using the OpenPGP standard as defined by RFC4880.  
Data transmitted on networks will be encrypted by Transport Layer Security or 
Secure Sockets Layer.   
The list of subjects and ID numbers will be encrypted with a different key than the 
key used to encrypt all of the other data.  
Cloud services the subjects and their parents already use include Minecraft and 
Google by the inclusion and exclusion criteria. These are all SaaS. The data aggregator to 
collect the subjects information from Minecraft in Google must have access to Google 
(PaaS) in order to create the backup at UK. 
CCTS personnel, PI, the trial Monitor, and the trial Auditor will have access to 
CRFs. CRF data will be recorded electronically because most of the data (which include 
the Minecraft Realm evolution over 4 weeks as recorded for backup purposes in save-sets, 
as well as subject reflections on gameplay for Minecraft, and logging of other video game 
play are in large data sets and only available in electronic form. Other CRF data include 
medical problems/issues, past illnesses as well as age at diagnosis, surgeries, amount of 
time subjects spend playing video games, gaming platform, typical length of playing 
session, video games previously played, age at which subject started playing, list/doses of 
current prescription, otc, and herbal supplements being taken, and height/weight. 
The de-identified CRF data listed above will be copied to a compact disk for 
archiving. The de-identified data will also be available in the UK repository. The data will 
be de- identified during the download process by removing fields tagged as identifiers as 
part of the download process. 
The CCTS study coordinator, will input the baseline NICHQ teacher scores into 
the eCRF from paper records if a teacher test record exists in participants’ files that is no  
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more than 1 month old, once subjects’ parents/legal guardians have given consent for the 
information to be accessed. 
Study and drug compliance records subjects make on their own Google Drives 
(Google is an inclusion criterion), as well as study reflection questions, will be shared by 
the subjects with the PI) online via Google, ensuring protection for data with personal 
identifying information (PII) or personal health information (PHI). The PI will 
automatically collect the shared data, which will be de-identified while still on Google and 
downloaded for backup to a password-protected single-user computer behind a firewall. 
Periodically and at the end of the study, the data will be downloaded to a password-
protected compact disk. 
3.11 Quality Assurance and Quality Control 
QC procedures will be implemented beginning with the data entry system and data 
QC checks for the database will be generated. Any missing data or data anomalies will be 
communicated to the site(s) for clarification/resolution. If for any reason the final NICHQ 
assessments from teachers are not available, the study will simply treat them as missing 
data. However, the initial assessment must be available for enrollment. 
The monitors will verify that the clinical trial is conducted and data are generated, 
documented (recorded), and reported in compliance with the protocol, and GCP. 
The investigational site will provide direct access to all trial related materials, 
source data/documents, and reports for the purpose of monitoring and auditing by the 
sponsor, and inspection by local and regulatory authorities. 
3.12 Ethics/Protection of Human Subjects 
3.12.1 Ethical Standard 
The investigator will ensure that this study is conducted in full conformity with 
Regulations for the Protection of Human Subjects of Research codified in 45 CFR Part 46, 
21 CFR Part 50, 21 CFR Part 56, and/or the ICH E6. 
3.12.2 Institutional Review Board 
The protocol, informed consent/assent form(s), recruitment materials, and all 
participant materials will be submitted to the IRB for review and approval. Approval of 
both the protocol and the consent and assent forms must be obtained before any participant 
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is enrolled. Any amendment to the protocol will require review and approval by the IRB 
before the changes are implemented to the study. All changes to the consent form will be 
IRB approved; a determination will be made regarding whether previously consented 
participants need to be re-consented. 
3.12.3 Informed Consent Process 
3.12.3.1 Consent/Assent and Other Informational Documents Provided to 
Participants 
Consent forms describing in detail the study agent, study procedures, and risks are 
given to the participant and written documentation of informed consent is required prior to 
starting intervention/administering study product. The following consent materials are 
submitted with this protocol: Informed Consent, Assent, web advertisement, activity list, 
video gaming log, drug compliance log, example self-assessment question list. 
There are two ways in which subjects may enter this trial. In the first way, subjects 
will be referred by their physician. In this case, the physician will obtain informed consent 
and assent. The second way is through advertisements. When a subject responds to an 
advertisement, the subject will have first contact with the research coordinator in the CCTS, 
and will be taken through the informed consent and assent process by the clinical research 
coordinator in the CCTS. The medical investigator or clinical research coordinator will 
explain the research study to the participant and answer any questions that may arise. The 
participant of legal age will sign the informed consent document prior to any procedures 
being done specifically for the study. A participant of less than legal age must sign an 
assent form, while that person’s parent or guardian must sign the consent document. The 
participants (i.e., the subject or the subject’s parent) may withdraw consent or assent at any 
time throughout the course of the trial. 
Informed consent is a process that is initiated prior to the individual’s agreeing to 
participate in the study and continues throughout the individual’s study participation. 
Extensive discussion of risks and possible benefits of participation will be provided to the 
participants and their families. Consent forms will be IRB-approved and the participant 
will be asked to read and review the document. The investigator will explain the research 
study to the participant and answer any questions that may arise. All participants will 
receive a verbal explanation in terms suited to their comprehension of the purposes, 
procedures, and potential risks of the study and of their rights as research participants. 
Participants will have the opportunity to carefully review the written consent form and ask 
questions prior to signing. The participants should have the opportunity to discuss the study 
with their surrogates or think about it prior to agreeing to participate. The participant will 
sign the informed consent document prior to any procedures being done specifically for the 
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study. The participants may withdraw consent at any time throughout the course of the 
trial. A copy of the informed consent document will be given to the participants for their 
records. The rights and welfare of the participants will be protected by emphasizing to them 
that the quality of their medical care will not be adversely affected if they decline to 
participate in this study. 
3.12.3.2 Consent Procedures and Documentation 
Informed consent is a process that is initiated prior to the individual’s agreeing to 
participate in the study and continues throughout the individual’s study participation. 
Extensive discussion of risks and possible benefits of participation will be provided to the 
participants and their families. Consent and Assent forms will be IRB-approved and the 
participant will be asked to read and review the document. The investigator will explain 
the research study to the participant and answer any questions that may arise. All 
participants will receive a verbal explanation in terms suited to their comprehension of the 
purposes, procedures, and potential risks of the study and of their rights as research 
participants. Participants will have the opportunity to carefully review the written consent 
and assent form and ask questions prior to signing. The participants should have the 
opportunity to discuss the study with their surrogates or think about it prior to agreeing to 
participate. The participant will sign the informed consent / assent document prior to any 
procedures being done specifically for the study. The participants may withdraw consent 
or assent at any time throughout the course of the trial. A copy of the informed consent / 
assent document will be given to the participants for their records. The rights and welfare 
of the participants will be protected by emphasizing to them that the quality of their medical 
care will not be adversely affected if they decline to participate in this study. 
3.12.4 Participant and Data Confidentiality 
Participant confidentiality is strictly held in trust by the participating investigators, 
their staff, and their agents. This confidentiality is extended to cover testing of biological 
samples and genetic tests in addition to the clinical information relating to participants. 
Therefore, the study protocol, documentation, data, and all other information generated 
will be held in strict confidence. No information concerning the study or the data will be 
released to any unauthorized third party without prior written approval of the sponsor. 
The study monitor, other authorized representatives of the sponsor, representatives 
of the IRB may inspect all documents and records required to be maintained by the 
investigator, including but not limited to, medical records (office, clinic, or hospital) and 
pharmacy records for the participants in this study. The clinical study site will permit access 
to such records. 
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The study participant’s contact information will be securely stored at each clinical 
site for internal use during the study. At the end of the study, all records will continue to 
be kept in a secure location for as long a period as dictated by local IRB and Institutional 
regulations. 
Study participant research data, which is for purposes of statistical analysis and 
scientific reporting, will be transmitted to and stored at the UK Data Repository and on 
password protected CD. This will not include the participant’s contact or identifying 
information. Rather, individual participants and their research data will be identified by a 
unique study identification number. The study data entry and study management systems 
used by clinical personnel and CCTS research staff will be secured and password protected. 
At the end of the study, all study databases will be de-identified and archived at the UK 
Data Repository. 
3.12.4.1 Research Use of Stored Human Samples, Specimens, or Data 
The investigator will assure that subject’s anonymity will be maintained. On CRFs 
or other documents submitted for analysis, subjects will not be identified by their names, 
but by an identification code. The investigator will keep a separate log of subjects’ codes 
and names. 
The data from this study may be used for additional analysis, but it will be coded 
or blinded data. Data collected for this study will be analyzed and stored by Investigator. 
After the study is completed, the de-identified, archived data will be transmitted to and 
stored at the Investigator/Sponsor’s lab, under the supervision of PI, for use by other 
researchers including those outside of the study. Permission to transmit de-identified raw 
data to the designated UK data repository will be included in the informed consent. 
3.12.5 Future Use of Stored Specimens 
Not applicable. 
3.13 Data Handling and Record Keeping 
3.13.1 Data Collection and Management Responsibilities 
All data will be entered on CRFs at each examination, reviewed and verified. To 
ensure accurate, complete, and reliable data, Investigator/Sponsor will do the following: 
Provide instructional material to study sites, as appropriate 
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Sponsor a start-up training session to instruct the investigators and study 
coordinators. This session will give instruction on the protocol, how to complete 
the CRFs, and study procedures. 
Periodic visits will be made to the study site 
Be available for consultation and stay in contact with study site personnel by mail, 
telephone, and/or fax 
Review and evaluate CRF data using standard computer algorithms to detect errors 
in data collection 
Conduct a quality review of the data base 
 
To ensure the safety of participants in the study, and to ensure accurate complete, 
and reliable data, the investigator will keep records including clinical notes, and subject 
medical records in the subject fields as original source documents for the study. If requested 
the investigator will provide the sponsor, applicable regulatory agencies, and applicable 
IRB with direct access to original source documents. 
Copies of the electronic CRF (eCRF) will be provided for use as source documents 
and maintained for recording data for each participant enrolled in the study. Data reported 
in the eCRF derived from source documents should be consistent with the source 
documents or the discrepancies should be explained and captured in a progress note and 
maintained in the participant’s official electronic study record. 
Clinical data (including AEs, concomitant medications, and expected adverse 
reactions data) will be entered into a file on Google Drive, a data capture system. Clinical 
data will be entered directly from the source documents, if necessary. 
This project will also use the multi-tenant infrastructure cloud provided by Google. 
The inclusion criteria will limit subjects to those who are already using Google services. 
Data, such as drug and study compliance logs and subject evaluation questions, will be 
uploaded to a secured Google Drive web page which uses Secure Sockets Layer for 
transmission and shared with Dr. Robert Lodder by the subject. The security and privacy 
controls are basically the same for everyone, with a few variations like two factor 
authentication. (The TVG project can only be accessed with two factor authentication on, 
but individual subjects have the option of using two factor authentication or leaving it 
turned off for their own data). 21 CFR part 11 compliance is gained by a business associate 
agreement with Google, by designing our security controls to interface with those specified 
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by the agreement with Google, and by following our SOP's (built around 21 CFR part 11 
compliance). 
3.13.2 Study Records Retention 
In order to comply with HIPAA requirements, IRBs generally require investigators 
to retain research records for six years after completion of the study158. However, most 
FDA regulations require records be kept at least 2 years post-marketing approval, which 
could be as long as 10-15 years in this particular case. Therefore, records will be kept 
minimally 6 years but possibly up to 15 years by the Sponsor/Investigator. Records, which 
are expected to be only electronic, will be maintained in a secure fashion with limited 
access, including additional controls to ensure password protection, authenticity, integrity, 
confidentiality of electronic records. 
3.13.3 Protocol Deviations 
A protocol deviation is any noncompliance with the clinical trial protocol or GCP 
requirements. The noncompliance may be either on the part of the participant, the 
investigator, or the study site staff. As a result of deviations, corrective actions are to be 
developed by the site and implemented promptly. 
 
These practices are consistent with ICH E6: 
Compliance with Protocol, sections 4.5.1, 4.5.2, and 4.5.3 
Quality Assurance and Quality Control, section 5.1.1 
Noncompliance, sections 5.20.1, and 5.20.2. 
 
It is the responsibility of the site to use continuous vigilance to identify and report 
deviations within 7 working days of identification of the protocol deviation, or within 7 
working days of the scheduled protocol-required activity. All deviations must be addressed 
in study source documents, reported to PI. Protocol deviations must be sent to the local 
IRB per their guidelines. The site PI/study staff is responsible for knowing and adhering to 
their IRB requirements. 
3.13.4 Publication and Data Sharing Policy 
This study will comply with the NIH Public Access Policy, which ensures that the 
public has access to the published results of NIH funded research. It requires scientists to 
submit final peer-reviewed journal manuscripts that arise from NIH funds to the digital 
archive PubMed Central upon acceptance for publication. 
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The International Committee of Medical Journal Editors (ICMJE) member journals 
have adopted a clinical trials registration policy as a condition for publication. The ICMJE 
defines a clinical trial as any research project that prospectively assigns human subjects to 
intervention or concurrent comparison or control groups to study the cause-and-effect 
relationship between a medical intervention and a health outcome. Medical interventions 
include drugs, surgical procedures, devices, behavioral treatments, process-of-care 
changes, and the like. Health outcomes include any biomedical or health-related measures 
obtained in patients or participants, including pharmacokinetic measures and adverse 
events. The ICMJE policy, and the Section 801 of the Food and Drug Administration 
Amendments Act of 2007, requires that all clinical trials be registered in a public trials 
registry such as ClinicalTrials.gov, which is sponsored by the National Library of 
Medicine. Other biomedical journals are considering adopting similar policies. For 
interventional clinical trials performed under NIH IC grants and cooperative agreements, 
it is the grantee’s responsibility to register the trial in an acceptable registry, so the research 
results may be considered for publication in ICMJE member journals. The ICMJE does not 
review specific studies to determine whether registration is necessary; instead, the 
committee recommends that researchers who have questions about the need to register err 
on the side of registration or consult the editorial office of the journal in which they wish 
to publish. 
3.14 Study Administration 
3.14.1 Study Leadership 
The Steering Committee will govern the conduct of the study. The Steering 
Committee will be composed of the Study PI, Co-Investigators, and Medical Investigators. 
The Steering Committee will meet in person as needed. 
3.15 Conflict of Interest Policy 
The independence of this study from any actual or perceived influence, such as by 
the pharmaceutical industry, is critical. Therefore any actual conflict of interest of persons 
who have a role in the design, conduct, analysis, publication, or any aspect of this trial will 
be disclosed and managed. Furthermore, persons who have a perceived conflict of interest 
will be required to have such conflicts managed in a way that is appropriate to their 
participation in the trial. The study leadership as well as the University of Kentucky has 
established policies and procedures for all study group members to disclose all conflicts of 
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interest and will establish a mechanism for the management of all reported dualities of 
interest. However, there are currently no conflicts of interest to disclose at this time among 
study leadership members. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
65 
 
CHAPTER 4. COMPUTATIONAL MODEL 
4.1 The Virtual “Subject” as a Computational Model 
To enable the computational simulation of tasks requiring the use of executive 
functions in humans, computational models representing the executive functions working 
memory and fluid intelligence were constructed. An impulsivity function was also built as 
a first step towards the construction of a model for the behavioral inhibition executive 
function. These virtual executive function models and the impulsivity function were then 
combined in a virtual Time Management activity requiring their combined use for its 
completion. In this context, the virtual “subject” is defined as the combination of the 
executive function models within the Time Management activity (Figure 10). 
Unique virtual “subjects” can be designed by varying the parameters of the 
executive function and impulsivity models. The working memory and fluid intelligence 
models contain ANNs, but the impulsivity function does not. As a result, the performance 
of the working memory and fluid intelligence models can be modified by varying the 
training parameters for their respective ANNs, but modification of the impulsivity function 
requires manual manipulation of its parameters.  
In this first implementation of the model, different groups of virtual “subjects” are 
created by varying the training procedures of ANNs to form groups that differ in the level 
of performance in the tasks that these ANNs are trained to perform. The training variations 
introduced here include the number of training examples presented to the ANNs during 
their learning and the duration of their training. When the efforts of multiple ANNs trained 
to perform single tasks are combined to work together on a larger, more complicated task, 
there will be a complex relationship between the set of training parameters for all the ANNs 
and performance on the larger task. If this relationship is defined as a function that receives 
the ANN training parameters as independent variables and transforms them into 
performance on the larger task as the dependent variable, an optimization problem can be 
created to maximize the improvement in performance that occurs with minimum variations 
in training. If this model can be developed to possess a sufficient amount of translational 
applicability to human subjects with executive function deficits, then the results of the 
optimization could provide guidance for designing interventions to treat these executive 
function deficits in humans.  
4.2 Generating Working Memory Deficiencies (Colab Notebook) 
As a first step towards the creation of a computational model of working memory 
deficiencies, convolutional neural networks (CNNs) were trained to identify handwritten 
digits in the MNIST dataset. The Keras Machine Learning library159 was used to create and 
train the CNNs and the experiment was run in a Google Colaboratory Notebook. In this 
implementation, the input of an MNIST image file into the first layer of the network is 
proposed to represent the holding of information in consciousness  
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Figure 10 – Building the Virtual “Subject” 
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component of working memory. The subsequent processing of this image pixel data by the 
internal network layers is proposed to represent the information manipulation component 
of working memory. Two groups of CNNs were created by varying the number of MNIST 
images (the size of the training set) used in their learning process. A “healthy” control 
working memory group consisted of CNNs trained to achieve high accuracy in the 
handwritten digit recognition task, while a “deficient” working memory group consisted of 
CNNs trained to achieve approximately half the accuracy of the “healthy” control group.  
All of the CNNs in both groups possessed an identical architecture, or structure of 
layers and connectivity between individual units. The architecture chosen was a modified 
version of the original historical CNN called lenet that was developed to identify 
handwritten digits in MNIST to automate zip code recognition for postal service28,160. The 
CNN architecture used here consist of two sets of convolutional and pooling layers, 
followed by two fully-connected layers, and a softmax classifier. As discussed in Chapter 
1, each unit in a convolutional layer is only connected to a limited set of the inputs provided 
by the previous layer. The first convolutional layer in a CNN receives the input data to the 
network (the image files themselves) as its input. The units in a convolutional layer are 
arranged in a three dimensional rectangular shape, and the units in each two dimensional 
“slice” of this rectangle shares the same set of weights and biases. The shared set of weights 
& biases for the units in each slice is called the kernel, and can be thought of as a filter that 
slides across the layer’s input to detect features that are used for determining the final 
output of the CNN. Each convolutional layer is followed by a pooling layer that reduces 
the number of parameters of the network by reducing the size of the convolutional layer’s 
output before it is used as an input for subsequent layers. Similar to the units in a 
convolutional layer, each unit in a pooling layer is also connected to a limited set of inputs 
and simply saves the maximum value of the inputs it receives. The two fully-connected 
layers reduce the quantity of outputs from the convolutional and pooling layers to the 
number of classes that the model predicts. In the case of the MNIST dataset, which contains 
images of the numbers 0-9, there are ten different classes. Finally, the softmax classifier162-
163 normalizes the output of the final fully-connected layer so that the sum of the outputs is 
equal to 1. This modification allows the interpretation of the final outputs of the network 
as a set of probabilities that the input to the network falls into each prediction class. For 
example, the CNN’s output for a given MNIST image consist of a set of 10 values, each of 
which represents the probability that the image contains a handwritten digit of one of the 
numbers 0-9.  
The structure of the CNN was modified by including a batch normalization layer163 
with each convolutional layer and using the rectified linear unit (ReLU) activation 
function164. The batch normalization layers reduce the magnitude of the variability in their 
inputs by subtracting each input by the mean of all inputs and then dividing each mean-
centered input by the standard deviation of all inputs. These layers are located after each 
convolutional layer and after the first fully connected layer of the network. They receive 
the net inputs calculated by the preceding layer, and the normalized outputs they calculate 
are passed on as inputs for the ReLU activation function. The ReLU activation function 
returns an output of zero for all input values < 0, and returns the original input value for all 
input values > 0.  Batch normalization layers help reduce overfitting of a neural network 
to training data, and the use of the ReLU activation function hastens the training time for 
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neural networks by avoiding the vanishing gradient problem161 associated with the use of 
other activation functions. 
 To generate deficiencies in this working memory representation, the relationship 
between the quantity of training examples and handwritten digit recognition performance 
of CNNs was first investigated. Five groups of identically structured CNNs (n = 10 x 
CNNS per group) were trained with sets of MNIST images with sizes in the range of 25 – 
50000 MNIST images per set. The MNIST images used for training were randomly 
selected from the training subset of the MNIST dataset, and randomly selected sets 
containing less than 100 MNIST images were checked to ensure that they contained at least 
one example image of each handwritten digit 0-9. Updates of the CNN parameters (weights 
& biases) were performed after training on batches of 25 MNIST images. The categorical 
cross-entropy loss function161 was used to measure the handwritten digit recognition 
performance of the CNNs during training and calculate the gradients of its weights and 
biases. The ADAM optimizer165 was then used to calculate the magnitude of the parameter 
updates from these gradients.  
 After training, the percent accuracy of handwritten digit recognition performance 
of each CNN was evaluated on the 10,000 MNIST images of the MNIST test set, and the 
mean accuracy of each group of CNNs was determined. As expected, the group mean 
handwritten digit recognition accuracy increased with increasing number of MNIST 
images presented during training (Figure 11). The minimum group accuracy achieved was 
44.3% (SD 4.1%) with 25 MNIST training images, and the maximum group accuracy 
achieved was 98.2% (SD 0.5%) with 50,000 MNIST training images. The observed 
relationship between group accuracy and the number of MNIST training images was 
logarithmic, and the rate of increase in performance was relatively minimal in groups 
trained with set sizes larger than 2,500 MNIST images (mean group accuracy = 95.7% (SD 
0.5%)). 
 Training procedures for the CNNs representing working memory in the virtual 
Time Management Task were selected to create a sizeable difference in performance 
between the “healthy” working memory control group with high handwritten digit 
recognition performance and the “deficient” working memory group with poor handwritten 
digit recognition performance in a minimal amount of computational time. Computational 
efficiency was prioritized over marginal improvements in accuracy in the selection of a 
training procedure for the “healthy” working memory control group. While a 2.5% 
improvement in group accuracy was observed from increasing the training set size from 
2,500 to 50,000 MNIST images, this improvement was achieved at a significant cost of 
increased computational time. Thus, a training set size of 2,500 MNIST images was 
selected to efficiently train CNNs in the “healthy” working memory control group to 
achieve a sufficiently high handwritten digit recognition performance.  
 The selection of a training procedure for the “deficient” working memory group 
was based on a similar consideration of weighing the level of performance achieved with 
the training time required to achieve the performance. A large performance decrement 
compared to the “healthy” working memory group was desirable in this case. The 
minimum accuracy achieved in this experiment was 44.3% (SD 41%) in the group trained 
with 25 MNIST images. While this level of accuracy could be decreased further by  
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Figure 11 – Effect of MNIST Training Set Size on MNIST TestSet Handwritten Digit 
Recognition of CNNs (n = 10 x CNNs per Group) 
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reducing the size of the training set, this decrease was achieved at a cost of significantly 
increased computational time to randomly select smaller training sets with at least one 
MNIST image containing each handwritten digit. Thus, a training set size of 25 MNIST 
images was selected to efficiently train CNNs in the “deficient” working memory group to 
achieve a sizable reduction in handwritten digit recognition performance compared to the 
“healthy” working memory control group.  
 To summarize, this investigation was performed to select training procedures for 
MNIST handwritten digit recognition by CNNs as a computational representation for 
working memory in humans. In this context, a “healthy” working memory was defined as 
high handwritten digit recognition performance by CNNs and a “deficient’ working 
memory was defined as poor handwritten digit recognition performance by CNNs. 
Differences in performance were created by varying the number of MNIST images used to 
train the CNNs. A training set size of 2,500 MNIST images was selected to generate CNNs 
with high handwritten digit recognition performance representing “healthy” working 
memory, while a training set size of 25 MNIST images was selected to generate CNNs 
with poor handwritten digit recognition performance representing “deficient” working 
memory. 
4.3 Prepotent Impulsivity 
As a first step towards the construction of a computational model for the behavioral 
inhibition executive function, the prepotent impulsivity function was created to generate 
impulsive behavior that may be inhibited. Prepotent responses are defined as unproductive 
behaviors that have been overlearned in a given circumstance, and are then used 
indiscriminately in other circumstances where they may no longer be appropriate7. This 
function was designed to be an addition to the MNIST handwritten digit recognition 
representation of working memory and activates unproductive behaviors resembling 
prepotent responses in this context.  
When the CNNs representing working memory were evaluated for their 
performance, their handwritten digit recognition accuracy was determined on an ordered 
test set. In other words, the CNNs were first presented with all the images containing a 
handwritten zero, then all the images containing a handwritten one, all the images 
containing a handwritten two, and so on. In contrast, this experiment was conducted with 
shuffled test sets where the images containing the various handwritten digits were 
presented to the CNNs in a random order. A shuffled test set will contain sub-sequences of 
different images containing the same handwritten digit. When these sub-sequences with 
consecutive images containing the same handwritten digit are presented to a CNN, a 
prepotent impulse is created. This prepotent impulse grows in strength as the number of 
consecutive digit repeats grows larger and promotes an automatic response with the 
identity of the repeated digit from the virtual “subject”. The automatic prepotent response 
is produced without the presentation of an MNIST image to the CNN, and is more likely 
to be incorrect than a non-impulsive response produced with the presentation of an MNIST 
image to the CNN. Thus, the prepotent impulsivity function can be considered a method to 
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produce erratic behaviors without the benefit of reasoning with executive functions 
(working memory) in this model.  
In addition to the prepotent impulse, the prepotent impulsivity function also 
includes a competing executive function-activating component. The executive function-
activating component supports the activation of a response determined by executive 
functions, specifically the presentation of an MNIST image to the CNN. The probability 
of carrying out an impulsive prepotent response is determined by subtracting the strength 
of this executive function-activating component from the strength of the prepotent impulse 
(Figure 12). 
Both the prepotent impulse and the executive function-activating component of the 
prepotent impulsivity function are Gaussian curves constructed with a strength parameter, 
an efficiency parameter, and a delay parameter. These curves are calculated with 
normalized time as the independent variable; this variable is considered an abstract 
representation of computational processing time and not a real time related to the 
computational task. The maximum values at the curves’ peaks are used to calculate the 
prepotent response probability. The strength parameter determines the magnitude of the 
curve’s peak, the efficiency parameter determines the rate at which the curve reaches its 
peak, and the delay parameter determines the location where the curve begins to grow. 
While the values of the parameters for the executive function-activating curve stay constant 
as the evaluation of the shuffled test set proceeds, the magnitude of the strength parameter 
for the prepotent impulse curve increases at a constant rate as MNIST images containing 
the same handwritten digit are encountered consecutively.  
The purpose of the prepotent impulsivity experiment was to determine whether this 
model could produce a significant difference in the performance of the working memory 
function. All calculations were performed with Wolfram Mathematica v11.1. In this 
experiment two groups of CNNs (n = 6 x CNNs per group) were generated with the training 
procedures described in Section 4.2 to produce a working memory deficient group and a 
“healthy” working memory group and their baseline handwritten digit recognition accuracy 
was evaluated on the MNIST test set. Both groups were then evaluated on six trials of 
shuffled test sets with the addition of the prepotent impulsivity function (all group 
“subjects” were evaluated with the same shuffled test set in each trial). The prepotent 
response was simply a repeat of the response given for the previously encountered image 
without giving the current MNIST image as an input to a CNN, while a non-impulsive 
response was generated by the CNN after presentation with the current MNIST image as 
an input. Both the difference in handwritten digit recognition performance between groups 
and the differences in handwritten digit recognition within each group with the addition of 
the prepotent impulsivity function were tested for significance with the Mann-Whitney U 
test. 
Results of this experiment are shown in Figure 13. After training for MNIST 
handwritten digit recognition, the “healthy” working memory group achieved a mean 
accuracy of 98.8% (SD 0.1%) while the “deficient” working memory group achieved a 
mean accuracy of 56.6% (SD 3.7%) on the MNIST test set. With the addition of the 
prepotent impulsivity function the “healthy” working memory group achieved a group  
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Figure 12 – Effects of Repeated Handwritten Digits on Prepotent Impulsivity Function  
(PI = Prepotent Impulse; EF = Executive Function-Activating Component; PR = Prepotent 
Response Probability) 
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Figure 13 – Effects of Prepotent Impulsivity Function on Group Mean Handwritten Digit 
Recognition Accuracy of CNNs on MNIST TestSet (n = 6 x CNNs per Working Memory 
Group) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
74 
 
mean accuracy of 89.9% (SD 0.2%) while the “deficient” working memory group achieved 
a group mean accuracy of 47.1% (SD 3.0%). Both the baseline difference in performance 
between the two working memory groups, and the differences in performance within each 
group resulting from the addition of the prepotent impulsivity function were significant. 
These results indicate that a statistically significant difference in handwritten digit 
recognition performance could be produced in both the “healthy” and “deficient” working 
memory groups with the addition of the prepotent impulsivity function. 
4.4 Generating Fluid Intelligence Deficiencies (Colaboratory Notebook) 
The higher order executive function fluid intelligence has been described in terms 
of the mental processes of analysis and synthesis7. The process of analysis involves the 
decomposition of complex information into smaller, simpler parts, while the process of 
synthesis involves the combination of simple pieces of information into more complex, 
novel combinations. The generation of sets of factors of the number 12 by basic recurrent 
neural networks (RNNs) is used as a representation of the synthesis component of fluid 
intelligence in this experiment, as the simple integers 1-10 are combined in varying ways 
until the more complex number 12 is produced. 
While CNNs are only capable of processing a single input at a time, RNNs are 
capable of processing sequences consisting of multiple inputs29. Although the architectures 
of RNNs can vary considerably in complexity, the simplest form of RNN possesses a single 
internal layer that changes its state as the sequence is processed and three sets of weight 
parameters. One set of weights processes the input to the network, another set of weights 
modifies the state of the internal layer of the network, and the third set of weights converts 
the inner state of the network into an output. The inner state of the network changes as each 
individual element of the input sequence is processed in a series of steps; this inner state is 
affected by the current element being processed as well as all the previously processed 
elements and determines the output that the network produces at each step. As a result, the 
output of the network at each step depends on both of the previously processed elements 
of the sequence and the currently processed element.  
To produce a list of integers that are factors of the number 12, the RNN produces a 
single predicted factor at each step, this predicted factor is recorded in a list containing all 
the previously predicted factors, and this set of previously predicted factors can then be 
used as an input for the RNN in the next step (Figure 14). This process repeats until the 
RNN produces an output indicating the output sequence is complete.  
All calculations for this experiment were performed with Python v3 in a Google 
Colaboratory Notebook. A basic RNN model modified from a RNN designed for language 
modeling and the generation of reddit comments166 was implemented. This RNN contained 
a single inner layer of 100 units, used the tanh activation function (a non-linear function 
with outputs ranging from -1 to 1) to calculate the inner layer, and a softmax activation 
function to generate a list of normalized probabilities for integers in the range 1-11 as an 
output. The number 0 was used as a “start token”, or initial  
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Figure 14 – Factor Prediction for the Number 12 by a Recurrent Neural Network 
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input to signal the start of a factorization prediction, while the number 11 was used as an 
“end token” to indicate the end of a sequence of predicted outputs. 
A training set composed of 29 training examples with features (inputs) and labels 
(correct outputs) were generated by hand. The set of training features consisted of lists of 
integers between 0 and 10, and the list for each training feature began with the integer 0. 
Lists of integers that could be multiplied together to produce the number 12 and lists of 
integers that that could not be multiplied together to produce the number 12 were both 
included. The set of training features lists that produced the number 12 included all the 
permutations of each set of factors, while the training features lists that did not produce the 
number 12 simply consisted of the start token 0 followed by the incorrect factor. A 
matching training label was created for each training feature. The training label for each 
example contained the same list of integers contained in the features for the example, but 
the start token 0 was removed and the end token 11 was added to the end of the list.  
Similar to the working memory function, modifications in a supervised learning 
training procedure were investigated to produce different categories of performance for the 
factorization of 12 in RNNs. In this case, the data available for training was limited (29 
training examples vs. 50,000 MNIST training examples) so the differences in performance 
were created by varying the number of training cycles (or epochs) as the independent 
variable rather than the number of training examples presented. All of the training 
examples are presented to a neural network in one training epoch, so the number of times 
a neural network sees each training example is equivalent to the number of training epochs. 
Ten groups of 12 x RNNs per group were assigned unique durations for their training 
ranging from 1 training epoch to 5,000 training epochs. The categorical cross-entropy loss 
function was used to measure the deviation between RNN outputs and correct predictions 
and calculate gradients to adjust parameter values. Stochastic gradient descent with a 
learning rate of 0.005 was used for the optimization method to adjust parameter values.  
After training, the performance of each RNN was evaluated by calculating its 
percent accuracy on 100 factorization of 12 predictions. As expected, the mean percent 
accuracy for the RNNs in each group increased with the number of training epochs in a 
logarithmic relationship (Figure 15). The minimum group mean accuracy was 0.5 % (SD 
0.9%) for the RNN group trained for 1 epoch while the maximum group mean accuracy 
achieved was 81.1% (SD 2.9%) for the RNN group trained for 5,000 epochs. The rate of 
improvement in performance began to level off at a group mean accuracy of 74.2% (SD 
5.4%) with 250 training epochs, although significant improvements in performance were 
still observed as the number of training epochs was increased further. 
 The training procedure for “deficient” fluid intelligence RNNs was selected to 
achieve a goal of approximately 50% mean factorization of 12 accuracy, while the training 
procedure for “healthy” fluid intelligence RNNs was selected with a consideration of 
performance and computational efficiency. The goal performance level for “deficient” 
fluid intelligence was achieved in RNNs trained for 75 epochs (group mean accuracy = 
48.3% (SD 4.1%). Training for 1000 epochs was selected as the learning procedure for 
“healthy” fluid intelligence RNNs to achieve a mean group accuracy of 77.6 % (SD 4.2%) 
with a sacrifice of 3.5% accuracy in exchange for significantly improved computational 
efficiency compared to training for 5000 epochs.  
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Figure 15 – Effect of Number of Training Epochs on Mean Group Accuracy of 
Factorization of 12 in Recurrent Neural Networks (n = 12 x RNNs Per Group) 
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In summary, a computational representation for the synthesis function of the higher 
order executive function fluid intelligence in humans was developed in this experiment. 
This model includes basic RNNs to predict integers between 1 and 10 that can be multiplied 
together to produce the number 12, where a “healthy” fluid intelligence is represented by 
RNNs with high factorization of 12 accuracy and a “deficient” fluid intelligence is 
represented by RNNs with poor factorization of 12 accuracy. This factorization of 12 fluid 
intelligence function was then integrated together with the MNIST handwritten digit 
recognition function representation for working memory and the prepotent impulsivity 
function to create the first implementation of virtual “subjects” who perform a virtual Time 
Management task. 
4.5 Time Management Task (Colaboratory Notebook) 
Similar to the fluid intelligence task described in Section 4.4, the goal of the Time 
Management task is to create a list of integers between 1 and 10 that can be multiplied 
together to produce the number 12. However, the process required to achieve this goal is 
modified in three important ways. Firstly, the Time Management task is not complete after 
a single factorization of 12 attempt, but rather continues until a successful factorization of 
12 is completed (Figure 16). Secondly, the Time Management task requires the use of the 
working memory function impeded by the prepotent impulsivity function for its 
completion. The working memory function with prepotent impulsivity is used after the 
prediction of a single factor to locate and correctly identify an MNIST image that contains 
the predicted factor as its handwritten digit in the MNIST test set. Finally, the performance 
of the Time Management task is measured by the total number of MNIST test set images 
searched through to complete a successful factorization of 12 rather than the percentage of 
successful factorizations.  
The procedure to create virtual “subjects” who complete the virtual Time 
Management task is simply a combination of the neural network training procedures 
developed in the preceding sections of this chapter. Each virtual “subject” consists of a 
working memory function consisting of a CNN trained for handwritten digit recognition in 
the MNIST test set, a set of parameters for the prepotent impulsivity function that impedes 
the performance of the working memory function, and a fluid intelligence function 
consisting of an RNN trained to factorize the number 12. Two groups of virtual “subjects” 
with n = 6 x virtual “subjects” per group are created: a control group with “healthy” 
working memory and fluid intelligence and an “ADHD” group with “deficient” working 
memory and fluid intelligence. Prepotent impulsivity was included in all “subjects” in both 
groups with the control group possessing a set of parameters that leads to lower impulsivity 
than the “subjects” in the “ADHD” group.  
All computations for the Time Management task were performed with Python 3 in 
a Google Colaboratory Notebook, and the creation and training of CNNs were performed 
with the Keras Machine Learning Library. Data visualizations were created in Wolfram 
Mathematica v11.1. ANNs for the virtual “subjects” in the control group were trained with  
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Figure 16 – Recurrent Neural Networks (Fluid Intelligence) in the Time Management Task 
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the learning procedures that produced 6x “healthy” working memory and 6x “healthy” 
fluid intelligence representations, while ANNs for the virtual “subjects” in the ADHD 
group were trained with the learning procedures that produced 6x “deficient” working 
memory and 6x “deficient” fluid intelligence representations. All ANNs (CNNs and 
RNNs) for each executive function representation possessed an identical architecture 
across both groups as described for CNNs in Section 4.2 and for RNNs in Section 4.3.  
“Healthy” working memory representations for six virtual control “subjects” were 
produced by training each of six CNNs with 2,500 handwritten digit images randomly 
selected from the MNIST training set and “deficient” working memories for six virtual 
“ADHD subjects” were produced by training each of six CNNs with 25 randomly selected 
MNIST training set images. Similarly, “healthy” fluid intelligence representations for six 
virtual control “subjects” were produced by training each of six basic RNNs for 1,000 
epochs to factorize the number 12 and “deficient” fluid intelligence representations for six 
virtual “ADHD subjects” were produced by training each of six basic RNNs for 75 training 
epochs. Baseline accuracies of the working memory representations were measured by 
handwritten digit recognition by CNNs on the MNIST test set while baseline accuracies of 
the fluid intelligence representations were determined on 100x factorization of 12 attempts 
by RNNs. The Mann-Whitney U test was used to test for significant differences between 
group means in baseline performance for each executive function representation. 
After training and evaluation of baseline performance of all ANNs, the Time 
Management task was performed by the virtual “subjects” (Figure 17). In the first step of 
the task, the virtual “subject’s” fluid intelligence representation uses a basic RNN to 
perform a single factor prediction. The identity of this factor is then provided to the virtual 
“subject’s” working memory representation with prepotent impulsivity, and the virtual 
“subject” begins to identify handwritten digits in randomly selected images from the 
MNIST test set. The virtual “subject’s” prepotent impulsivity function is operational with 
each identification, and may activate an automatic impulsive response where the virtual 
“subject” simply responds with its previous handwritten digit recognition output rather than 
using its working memory representation to identify the handwritten digit with a CNN. As 
described in Section 4.3, the automatic impulsive response becomes more likely as multiple 
MNIST images containing the same handwritten digit are encountered in succession. This 
search continues until the predicted factor is located AND correctly identified in the 
MNIST test set. Once the search is successfully completed, another factor prediction is 
performed and this sequence of steps continues until a complete factor list is predicted and 
all of its elements are correctly identified in the MNIST test set. If a correct factor list is 
predicted one trial of the task is complete. Otherwise, this procedure is repeated until a 
correct factor list is produced. Each virtual “subject” completed 25 successful 
factorizations of 12 trials, and a mean MNIST test set images searched count for all the 
trials was calculated for each “subject”. The Mann-Whitney U Test was then used to test 
the group mean images searched counts for significant differences.  
Without prepotent impulsivity, virtual “subjects” in the “healthy” control group 
achieved a baseline group mean handwritten digit recognition accuracy of 95.9% (SD 
0.9%) while virtual “subjects” in the “ADHD” group achieved a baseline group mean 
handwritten digit recognition accuracy of 39.2% (SD 5.1%) on the MNIST test set (Figure 
18).  
81 
 
Figure 17 – Time Management Task Flowchart 
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Figure 18 – Baseline Difference in Mean Group Accuracy of Handwritten Digit 
Recognition on MNIST TestSet by Convolutional Neural Networks of Virtual “Subjects” 
in the Time Management Task (n = 6 x CNNs Per Group) 
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A Mann-Whitney U Test showed a significant difference between the groups (p = 0.025). 
For comparison, in the Generating Working Memory Deficiencies experiment (Section 
4.2) the CNN-group trained with a random set of 2,500 MNIST images achieved a mean 
group accuracy of 95.7% (SD 0.5%), while the CNN-group trained with a random set of 
25 MNIST images achieved a mean group accuracy of 44.3% (SD 4.1%) in handwritten 
digit recognition on the MNIST test set. A Mann-Whitney U test comparing the results of 
each group between different experiments resulted in non-significant differences for both 
groups (p = 0.704 and p = 0.0577 for the “healthy” and “deficient” groups, respectively). 
Taken  together, these data indicate that a significant difference in performance of the 
working memory function was successfully produced between the virtual “subjects” in the 
“healthy” control and “ADHD” groups, and the working memory deficiency results in this 
experiment were consistent with the results of the previous experiment.   
Virtual “subjects” in the “healthy” control group achieved a baseline group mean 
factorization of 12 accuracy of 79.5% (SD 4.0%) while virtual “subjects” in the “ADHD” 
group achieved a baseline group mean factorization of 12 accuracy of 47.3% (SD 4.7%) 
(Figure 19). A Mann-Whitney U Test revealed a significant difference between groups (p 
= 0.025). For comparison, in the Generating Fluid Intelligence Deficiencies experiment 
(Section 4.3) the RNN-group trained for 1,000 epochs achieved a mean group accuracy of 
77.6% (SD 4.2%), while the RNN-group trained for 75 epochs achieved a mean group 
accuracy of 48.3% (SD 4.1%) on the factorization of 12 activity. A Mann-Whitney U test 
comparing the results of each group between different experiments showed non-significant 
differences for both groups (p = 0.479 and p = 0.707 for the “healthy” and “deficient” 
groups, respectively). Taken together, these data indicate that a significant difference in 
performance of the fluid intelligence function was successfully produced between the 
virtual “subjects” in the “healthy” control and “ADHD” groups, and the fluid intelligence 
deficiency results in this experiment were consistent with the results of the previous 
experiment. 
Finally, virtual “subjects” in the “healthy” control group required a group mean of 
37.4 (SD 2.5) MNIST test set images searched through, while virtual “subjects” in the 
“ADHD” group required a group mean of 579.1 (SD 352.3) MNIST test set images 
searched through to complete the virtual Time Management task (Figure 20). A Mann-
Whitney U Test showed a significant difference between groups (p = 0.0025). These results 
indicated that this model composed of virtual “subjects” built from executive function 
representations of working memory and fluid intelligence with impulsivity that complete a 
virtual Time Management task that requires the use of these executive function 
representations was able to produce two groups of “subjects” with distinct levels of 
performance in the virtual task. 
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Figure 19 – Baseline Difference in Mean Group Accuracy of Factorization of 12 by 
Recurrent Neural Networks of Virtual “Subjects” in the Time Management Task (n = 6 x 
RNNs Per Group) 
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Figure 20 – Performance of Virtual “Subjects” in the Time Management Task (n = 6 x 
Virtual “Subjects” Per Group) 
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CHAPTER 5. DISCUSSION 
In summary, a virtual Time Management task utilizing convolutional neural 
networks, recurrent neural networks, and the MNIST dataset was designed as a first step 
towards the development of a virtual subject. This virtual subject will be used as a 
computational model to guide the selection of personalized treatment regimens for the 
training of executive functions in children with ADHD. The virtual Time Management task 
requires the use of a working memory function composed of a convolutional neural 
network trained to identify handwritten digits in the MNIST dataset, as well as an 
impulsivity function that produces impulsive responses. Recurrent neural networks trained 
to output sequences of integers that are factors of the number 12 are used to represent a 
simplified fluid intelligence function. Thus, the virtual Time Management task that was 
developed required this first version of a virtual subject to use both a working memory 
function, hindered by an impulsivity function that produces impulsive responses, and a 
fluid intelligence function for its successful completion. The remainder of this chapter will 
first address general limitations of the computational models, then describe the 
development of each executive function model in more detail, and conclude with a 
discussion of approaches to improve the translational applicability of the computational 
model to human subjects and the progress of the TVG pilot study. 
The overall design of this project is limited in two important ways. First, it is 
unlikely that a therapeutic video game intervention will be sufficient for addressing the full 
scope of impairments present in ADHD. The executive function theory for ADHD has not 
proven to be a complete description of the neuropsychological impairments present in this 
disease. A meta-analysis investigating the likelihood of executive function deficits being 
the primary cause of ADHD found that these deficits were not present in all the study’s 
subjects, and their presence only exerted a moderate effect size on ADHD symptoms167. 
Executive function deficits in ADHD have also proven to be heterogeneous in nature, and 
inhibition deficits are not present in every patient168. Notably, this latter finding is contrary 
to Barkley’s proposal of a central deficit in inhibition being responsible for the 
development of ADHD7. Taken together, these results indicate that executive function 
deficits are neither necessary nor sufficient to cause the development of ADHD. 
Furthermore, new multiple pathways theories have emerged that incorporate executive 
function deficits as a single pathway together with an excessive motivation to avoid 
delays169 and temporal processing deficits170. Therefore, the targeting of executive function 
impairments alone will not be an effective approach for the treatment of ADHD.   
Even if the targeting of executive function deficits does not prove to be a method 
to correct the full scope of impairments in ADHD, this strategy may nonetheless be of use 
to improve the functioning of children with ADHD. In addition, the personalized treatment 
strategy of the therapeutic video games intervention remains an advantageous approach to 
address a heterogeneous set of impairments such as those in ADHD due to the highly 
individualized treatment recommendations it may prove to offer. The flexibility of the 
Minecraft environment would also permit the development of additional tasks to target 
neuropsychological deficits in non-executive function domains.  
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Secondly, while the artificial neural networks used in the computational model of 
executive function deficits bear some similarity to biological neural networks, they 
nonetheless remain a profoundly simplified approximation. A complete discussion of these 
simplifications is beyond the scope of this work, but a few illustrative limitations are worth 
pointing out here.  
The most significant limitation of artificial neural networks as a model for 
neurological activity may be their simplified representation of the structure and function of 
biological neural networks. Although the design of a single feed-forward network with 
multiple layers may resemble the structure of a biological network composed of multiple 
neurons working in tandem, this kind of network might more closely resemble the 
structural complexity of an individual branch of a dendritic tree in a single neuron171. As a 
result, even the largest artificial neural network models in use would not be capable of 
achieving computational complexity that a single neuron is capable of producing. 
An important functional simplification in artificial neural networks is the exclusion 
of spatial and temporal information from their design172. Whereas the spatial distribution 
of input signals to the dendritic tree of a biological neuron is an important factor for the 
processing of these inputs, this factor is not accounted for in commonly used artificial 
neural networks. Furthermore, the functioning of the current generation of artificial neural 
networks relies on the rate code approximation, which means that all the inputs and outputs 
in a network model are represented as average firing rates of electrical impulses in 
synapses. In contrast, biological neurons interpret the patterns of input signals they receive 
and convey important information in the patterns of the output signals they produce.  
 New generations of artificial neural networks currently under development hold 
promise for the amelioration of the functional limitations in the current generation of 
network models. For example, spiking neural networks are designed to more accurately 
model the temporal function of real neurons, and are currently under development as a 
computational tool for widespread use173. Spiking neural networks utilize differential 
equations to incorporate temporal input information as biological neural networks do, but 
their use is currently limited by difficulties in their training procedures. These, and other 
neural networks systems under development, may increase the computational power of 
artificial neural networks over time to improve their capability to model the function of 
biological neural networks more accurately. 
5.1 Working Memory 
Working memory is defined as the ability to hold information in consciousness 
(short-term memory) and manipulate it2. This definition leads to the rationalization for the 
use of image identification by convolutional neural networks as a model for working 
memory. In the current implementation, the input of an MNIST image file into the first 
layer of the network is proposed to represent the holding of information in consciousness 
component of working memory, and the subsequent processing of this input data by the 
internal network layers is proposed to represent the manipulation component of working 
memory.  
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The input of data into the network as the short-term memory component of working 
memory admittedly is not a strong representation of this mental ability for two reasons. 
First, the data provided as input to the convolutional neural network is the actual MNIST 
example data itself, so there is no recall mechanism to produce an internal representation 
of this MNIST example data in its absence. Second, there is no holding mechanism to 
maintain this internal representation of the data over time to allow its manipulation. Thus, 
the working memory function could be improved through the addition of data recall and 
holding mechanisms to the convolutional neural network. The recall mechanism would 
operate prior to the input of data to the convolutional neural network, while the holding 
mechanism would operate simultaneously with the processing of the input data in each 
hidden layer of the convolutional neural network. These modifications could potentially 
improve the resemblance of this working memory function to the function of working 
memory in biological neural networks by including a simplified representation of the 
biological short-term memory component while maintaining a manageable level of 
computational complexity. 
Although several neural network models have been proposed to represent the short-
term memory component of working memory174, a degree of redundancy may exist in the 
actual biological neural networks that are responsible for this executive function so no 
single computational process is responsible for biological working memory in all cases175. 
Two examples of artificial neural network models for modeling biological working 
memory include cell assemblies and synfire chains. Cell assemblies176 consist of strongly 
interconnected groups of neurons in a Hopfield model that maintain a persistent excitation 
pattern over time through their mutual activation. Here, the outputs of a given group of 
neurons at one instance in time is used as the input for this same group of neurons in the 
next instance to produce a recurrent firing pattern. The excitation pattern maintained by 
cell assemblies is a representation of a piece of information held in short-term memory, 
and this model relies on the use of the leaky-integrator differential equation to model the 
temporal dynamics of input currents and firing rates of individual neurons. Synfire 
chains177 also rely on the leaky-integrator differential equation to model their temporal 
dynamics, but use a feedforward neural network model rather than a recurrent Hopfield 
model. While the standard feedforward neural networks have the individual neurons in 
each layer firing at varying rates, individual groups of neurons/layers in synfire chains all 
fire simultaneously in time, and produce a persistent chain of spikes across multiple layers 
that represent the piece of information held in short-term memory. These models have been 
developed from the biophysical properties of individual neurons’ dynamic function, and 
therefore attempt to capture a level of complexity that is too great for the purposes of this 
project at this time. Nevertheless, much of this complexity may be obviated with the 
selection and design of simpler models that ignore these temporal dynamics of neural 
function while still representing similar functions. 
To represent the recall mechanism of short-term memory, an autoassociative 
memory linear associator network trained by supervised Hebbian Learning9 could be 
utilized. This type of network could potentially be trained to produce an MNIST image as 
an output when similar MNIST images are presented as inputs. With proper training, the 
output of such networks would provide accurate representations of MNIST images, even 
when provided with a corrupted version of a given image as its input. Hence, a properly 
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trained network with an effective recall would reproduce high-quality MNIST images as 
outputs when provided with altered MNIST images as inputs, whereas a poorly trained 
network with an ineffective recall would produce poor-quality MNIST images as outputs. 
These reproduced versions of MNIST images would then be provided as inputs to the 
manipulation function represented by convolutional neural networks in the current 
implementation of the working memory model. The high-quality MNIST images produced 
by well-trained linear associator networks with effective recall would enable more effective 
performance of the manipulation function represented by convolutional neural networks 
and result in a higher probability of a correct handwritten digit identification and more 
effective use of working memory as a whole. In contrast, the low-quality MNIST images 
produced by poorly-trained linear associator networks with ineffective recall would impede 
the performance of the manipulation function represented by convolutional neural 
networks and result in a lower probability of a correct handwritten digit identification and 
less effective use of working memory as a whole. 
One potential approach to represent the holding mechanism of short-term memory 
is to interfere with the passage of information between individual layers of the 
convolutional neural network during the operation of the manipulation function. Although 
the original input data is transformed with each passage from layer to layer, it can still be 
considered a modified representation of the original information and therefore the act of 
transferring the output from one layer as an input to the next layer could be considered 
analogous to holding the information being manipulated. Within this context, a 
dysfunctional holding mechanism could be represented with an ineffective transfer of 
information between layers (by randomly corrupting the data values before they are input 
into a layer, for example) and an effective holding mechanism could be represented by an 
unimpeded transfer of information between layers. 
5.2 Impulsivity & Inhibition 
The design of the impulsivity function was influenced by both the race model and 
the passive-dissipation hypothesis for the control of impulsive behavior. These theories 
have been used to explain the results observed in the stop-signal task, which is a behavioral 
task requiring the use of inhibitory control. Both of these theories describe impulsive 
responses and their inhibition in terms of mental processes that grow in strength over time 
and compete to reach a threshold value that activates a behavioral response. These theories 
differ in the mechanism of impulsive behavior prevention, as the passive-dissipation 
hypothesis includes an active role for inhibitory control (described below). The impulsivity 
function in the current project was designed to represent the mental processes that compete 
to produce behavioral responses as described in these theories. However, the role of the 
impulsivity function at this time is the generation of impulsive behaviors rather than their 
inhibition, although the design of an inhibitory control component that works as described 
in the passive-dissipation hypothesis remains to be addressed in future work. 
The race model has been used to describe the mental processing of prepotent 
responses and their inhibition in the stop signal task177. Prepotent responses are a category 
of behavioral responses to stimuli for which immediate reinforcement is presently available 
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or has been available in the past, and were identified as a target for the behavioral inhibition 
executive function in Barkley’s influential executive function theory for ADHD7. 
Prepotent responses can be overlearned behaviors, occur impulsively without reflection, 
and can oftentimes conflict with long-term goals. All individual trials in the stop signal 
task contain a “go” signal that requires the experimental subject to select a response. A 
subset of these trials also include the presentation of a “stop” signal at varying time 
intervals after the “go” signal has been presented, and require the experimental subject to 
withhold the selection of a response. The presentation of the “stop” signal after the “go” 
signal is significant in that the mental processing for responding to the “go” signal is 
already active when the “stop” signal is presented. The race model proposes that these 
processes are independent and compete to produce a behavioral response, and the resulting 
behavioral response is activated by the process that reaches a given threshold more rapidly 
in time.  
The passive-dissipation hypothesis178 builds on the race model by allowing the 
prepotent response to be overcome by the use of the executive function of inhibition to 
create a delay in the decision to respond. This delay allows the slower correct response to 
continue growing in strength to reach the response threshold as the prepotent response 
dissipates. While the use of the executive function inhibition is not included in this project, 
the impulsivity function was designed to allow for the use of inhibition to create a delay in 
the decision to respond. When this delay occurs the slower mental process for an 
appropriate response grows in strength and exerts a greater influence on the decision-
making process. 
The impulsivity function was developed to produce prepotent responses during the 
operation of the working memory function as the convolutional neural network identifies 
handwritten digits in the shuffled MNIST test set. The prepotent responses are generated 
by the impulsivity function when multiple examples of MNIST images are encountered in 
a row during the operation of the working memory function. Every time a subsequent 
image containing the same digit as the previously encountered image is presented as an 
input to the convolutional neural network, positive reinforcement is provided for a correct 
response to that digit and the strength of the prepotency for this response grows. Then, 
when an image containing a different handwritten digit is encountered, this previously 
reinforced prepotent response may be activated and lead to an incorrect response. The 
likelihood of activation of the prepotent response may be reduced by an executive function 
response, however, and the prevailing behavioral response is determined by the relative 
strength of these two competing responses. 
The impulsivity function attempts to model the mental processes that compete to 
produce either impulsive behaviors or more carefully considered productive behaviors. 
This initial implementation of the impulsivity function is limited to a prepotent response 
(PR) process curve and an executive function (EF) process curve. These mental process 
curves are generated from a strength parameter, efficiency parameter, and delay parameter. 
The strength parameter determines the size of the curve’s peak, the efficiency parameter 
determines how rapidly the curve reaches its peak, and the delay parameter indicates the 
time delay from presentation of the stimulus to when the mental process curve initiates. A 
behavioral response is determined by subtracting the value of the EF process curve from 
the value of the PR process curve at the decision point to produce a prepotent response 
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probability (PRP). The PRP is then compared to a randomly generated value between 0 & 
1 (RV). If the PRP is greater than RV a prepotent response is initiated, otherwise a non-
impulsive response is initiated.  
Importantly, the EF process curve described above represents the application of a 
set of executive function processes that are distinct from the behavioral inhibition executive 
function. The EF process curves are dedicated towards the creation of productive 
behaviors, whereas the behavioral inhibition executive function is dedicated towards the 
delay of the decision point to allow these EF process curves to overcome the opposition of 
the PR process curve that activates unproductive, impulsive behavior. In this example, the 
EF process curve represents the strength of the mental process that activates the use of 
working memory through a trained convolutional neural network to identify a handwritten 
digit, while the PR process curve represents the strength of the mental process that bypasses 
the use of working memory in the formation of a response that is less likely to be correct. 
The addition of a behavioral inhibition executive function in future implementations of the 
impulsivity function would delay the decision point and thus allow for the EF process curve 
to grow in strength while the PR process curve weakens. As a result, the PRP would 
decrease and the likelihood of the initiation of a productive behavior would increase. 
Similar to the impulsivity function, both the race model and passive-dissipation 
hypothesis describe impulsive behaviors and their inhibition in terms of competing mental 
processes. However, while the race model and passive-dissipation hypothesis define this 
competition as a race in time between mental processes to reach a given threshold value, 
the impulsivity function defines this competition in terms of the relative magnitudes of the 
outputs of the mental processes. In other words, the race model and passive-dissipation 
hypothesis describe the resulting behavioral response as an outcome of only one of the 
mental processes, while the impulsivity function defines the behavioral response as an 
outcome of an interaction between both mental processes. In the race model the winning 
process is simply the process which reaches the threshold first, while in the passive-
dissipation hypothesis the winning process is the one which reaches the threshold when the 
decision to act is made. In contrast, the impulsivity function implements the resulting 
behavioral response as the outcome of an interaction between both of the mental processes 
by subtracting the strengths of the outputs of the mental processes.  
This initial implementation of the impulsivity function was designed to create 
impulsive responses to interfere with the operation of the working memory function in the 
absence of any influence from behavioral inhibition. Thus, the current version of the 
impulsivity function simply defines the decision point as the time when the PR process 
curve reaches its peak value, which is when the PR process exerts its maximum effect on 
the behavioral response and the EF process exerts a relatively minor effect. However, a 
behavioral inhibition delay parameter may be added in future implementations of the 
impulsivity function to create a delay of the decision point to allow for the PR process to 
weaken as the EF process strengthens, leading to a greater opportunity for the application 
of a productive behavioral response as reflected in a decreased PRP value. 
Two alternative computational methods that have been used for modeling inhibition 
are the negative bias weight learning mechanism and the drift-diffusion model. The 
negative bias weight learning mechanism179 was applied within the context of a dynamic 
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gating neural network model for a task-switching activity similar to the Wisconsin card 
sorting task, which is a psychological test used to measure cognitive flexibility180. The 
dynamic gating model utilizes a feedforward network with a single hidden layer that is 
connected to another layer representing the pre-frontal cortex. This pre-frontal cortex layer 
learns representations of the various rules governing appropriate responding in the task. As 
the task proceeds, the active rule changes and the neural network’s pattern of responding 
must also change accordingly to avoid making erroneous responses resulting from the 
previously active rule. The negative bias weight learning mechanism inhibits responses 
from the previous rule by rapidly decreasing the values of the weights for the units 
representing this previous rule to a large negative value, making these units inactive. These 
weights are then allowed to gradually return to increase to zero as the task continues to lift 
the inhibition. The negative bias weight learning mechanism operates within the context of 
the continuous training of a neural network as it performs a given task. In contrast, the 
impulsivity function operates as an external precursor to the CNNs in this model, and 
therefore the negative bias weight learning mechanism would not be compatible with this 
current approach.  
A potential alternative method for the computational modeling of behavioral 
inhibition processes is the drift diffusion model181. The drift diffusion model has garnered 
interest in computational psychiatry to model decision-making processes182, and the 
parameters of this model have been linked to neural functions183-186. It has been utilized for 
the modeling of decision-making processes in two-choice decision tests181,  including tests 
measuring inhibitory control, such as the go/no-go task183 and the stop-signal task187. In the 
case of the go/no-go task, the drift-diffusion model was used to analyze reaction time data 
in subjects with ADHD to compare predictions between theories of ADHD188-189, while the 
capability of the model to represent the results of a rational decision-making process 
involving Bayesian inference was investigated in the case of the stop-signal task187. 
The drift diffusion model has been useful for modeling simple one- or two-choice 
decisions183, where the selection of a decision is determined by one or more stochastic drift 
processes that move towards boundaries representing the available decisions. The 
stochasticity in the model is incorporated through the addition of random noise to the 
movement of the drift processes as they travel towards a boundary. When the movement 
of the drift process reaches one of the boundaries, a decision to complete the action 
represented by that boundary is made.  
The drift diffusion model consists of the following parameters: a start point (z), the 
boundary separation (a), the drift rate (v), and non-decision process time (ter). After a time 
delay representing the encoding of a stimulus, the start point z is reached. The start point z 
may be located closer to one or the other of the boundaries, depending on an individual’s 
expectations of the correct response in the decision making task. The distance between the 
boundaries representing each decision is represented by the boundary separation a, which 
is determined the amount of information required by an individual to make a decision and 
the individual’s decision-making strategy, such as a speed-accuracy trade-off. For 
example, an individual with a greater concern for accuracy than speed would require a 
greater amount of information before making a decision, and a greater boundary separation 
would result. In contrast, an individual with a greater concern for speed than accuracy 
would require less information to make a decision and possess a smaller separation between 
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the boundaries representing their decisions in this model. The drift rate v represents the 
rate at which the sensory information required for an individual to make a decision 
accumulates, and is affected by the individual’s level of arousal. In the case of an individual 
with low arousal, such as a subject with ADHD for example, this information would 
accumulate more slowly and a longer time would be required for this individual to make a 
decision than an individual with higher arousal. Finally, the non-decision process time ter 
represents the times required for the encoding of the stimulus before the drift process 
initiates and for the motor processing of the behavior representing the decision after the 
drift process is completed. 
In the case of the Go/No-Go task where the inhibition of a prepotent response is 
considered, there would be two possible decisions (go and no-go) represented by two 
boundaries and a single drift process that ends when one of these boundaries is reached. 
However, in the case of the stop-signal task where the inhibition of an ongoing response is 
considered, there are two drift processes that occur. The first of these is similar to the single 
drift process of the Go/No-Go task that proceeds towards one of two decision boundaries, 
while the second represents the additional inhibition process that must be initiated to 
prevent the ongoing response. This second drift process begins later in time than the initial 
drift process representing the mental processing of the decision that must be inhibited; the 
drift process that is completed sooner in time activates the decision to respond or not to 
respond, as described in the race model. 
In contrast to the negative bias weight learning mechanism described earlier in this 
section, the drift-diffusion model offers a viable alternative for the representation of 
impulsive behaviors and their inhibition currently offered by the impulsivity function. 
While the drift-diffusion model has a stronger record of evidence for its use, to our 
knowledge its application has been limited to the modeling of decision-making in simple 
one- or two-choice decision-making tasks. A complex gaming environment such as 
Minecraft, however, presents dynamic decision-making scenarios where more choices may 
be available at any given moment and choices are continuously removed or added as 
circumstances change. It is foreseeable that higher complexity environments could present 
decision-making scenarios that require alternative criteria for inhibitory decision-making 
that extend beyond the time-based processing of alternatives by the drift-diffusion model. 
Therefore, the use of multiple inhibitory decision-making models may be advantageous in 
this project to determine whether different models may work more effectively in different 
varieties of decision-making scenarios. 
5.3 Fluid Intelligence 
The Factorization of 12 task using basic RNNs to output factor sets of the number 
12 was used as a representation for the synthesis component of fluid intelligence in this 
experiment. This task can be improved by the inclusion of a representation for the process 
of analysis to create a more comprehensive model of fluid intelligence and by adopting a 
different variety of RNN to increase the complexity of the task. Consider the process of 
analysis (breaking down complex ideas) as the inverse of the process of synthesis (building 
up complex ideas). When the process of synthesis is then represented as the building up of 
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the “complex” number 12 from its simpler component factors, the process of analysis may 
be represented as the breaking down of the number 12 into its simpler component factors. 
Thus, the fluid intelligence operation that currently consists of the process of synthesis will 
be expanded to include an RNN task to break down the number 12 as a representation for 
the process of analysis.  
In the current version of the task, the RNN begins by producing a factor of the 
number 12, which is then used as an input in the next loop of the task for the RNN to output 
another factor. This process continues until the RNN produces an output to indicate the end 
of the sequence of factors and then concludes with an evaluation of the accuracy of the 
sequence. The reverse process can be implemented through the modification of the RNN’s 
training set. The training set will be differentiated into two separate categories, where one 
category consists of factor sequences with factors ordered from smallest to largest in size 
and vice-versa for the other category. The training set with examples ordered by increasing 
size of their factors will train RNNs for the process of synthesis (where the larger number 
is assembled), while the training set with examples ordered by decreasing size will train 
RNNs for the process of analysis (where the larger number is broken down).  
An additional improvement is the substitution of the basic RNNs with Long-Short 
Term Memory networks (LSTMs). While basic RNNs indiscriminately update every 
parameter of their internal layer with each step of the sequence they produce, LSTMs 
include additional “forget” gates in this updating process that screen for and exclude the 
passage of extraneous information to the internal layer between steps in the sequence. This 
increased efficiency of updating permits the processing of larger sequences in LSTMs, and 
thus LSTMs would be beneficial to permit the analysis and synthesis of larger numbers in 
this project. The capability to process larger numbers in this way would allow the creation 
of multiple difficulty levels for the task to more accurately capture the properties of the 
therapeutic video games tasks which have multiple difficulty levels. 
A comparison of this work to alternative modeling approaches is difficult due to a 
paucity of research related to the neural functions that produce fluid intelligence. The 
function of a network of brain regions known collectively as the Multiple-Demand System 
has been proposed to play a general role across multiple complex problem solving tasks in 
primates190. Detailed functional neural network theories are lacking however. While a 
recent theory has proposed that fluid intelligence results from a widespread, randomly 
connected network structure of groups of neurons6, to our knowledge there does not seem 
to be any research available that examines the computations that these types of networks 
conduct. 
5.4 Translation to Human Subjects 
The translational applicability of this model to the treatment of executive function 
deficits in humans with ADHD could be improved with the development of an assessment 
tool, similar to the NICHQ assessment used in the clinical pilot study, to measure 
simplified ADHD-like behaviors in the virtual “subjects”. The NICHQ is completed by 
parents and teachers who observe a child with ADHD, so the assessment tool for the 
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computational model will also be completed by trained observers who will monitor the 
actions of the virtual “subjects”. With the inclusion of this virtual “NICHQ” tool, the 
changes in performance resulting from modifications in the training procedures of the 
ANNs would be determined not only by their final performance on a complex virtual 
activity, but also their “behavior” as they complete the activity.   
To increase the translational applicability of the virtual “NICHQ”, its assessment 
questions will be designed to be as similar as possible to the questions of the actual NICHQ 
in humans. Many of the behaviors measured by the NICHQ involve the interaction of a 
child with their peers and environment. To simulate these interactive behaviors, it will be 
necessary to develop an interactive environment for the ANNs. One potential method to do 
so would be to program the ANNs to function within the Minecraft environment itself that 
is used as the platform for the therapeutic video game executive function training activities. 
In fact, CNNs have been trained with reinforcement learning to function in Minecraft191. 
However, a simpler approach to implement would be to continue using the supervised 
learning approach in this model, but create an environment with multiple virtual “subjects” 
working side-by-side by parallelizing the computations to run across multiple processors 
simultaneously in a cloud environment. This way, the current implementation of the model 
could still be used to produce an interactive environment with the creation of additional 
functions to enable interactions between the ANNs of multiple virtual “subjects”.  
5.5 Clinical Pilot Study 
At the present moment, the progress of the clinical pilot study of the TVG 
intervention has been slower than expected due to difficulties with patient recruitment. To 
accelerate the progress of recruitment, a contract research organization (CRO) was hired 
to manage the operations of the clinical study. However, further consideration of the nature 
of the patient recruitment difficulties may be instructive as a source of guidance for the 
improvement of the therapeutic video game intervention for future clinical studies.  
 One potential reason for these recruitment difficulties is the complexity of the study 
intervention. The study group completing the video game intervention requires an 
investment of 150 minutes of Minecraft game play per week (Section 3.1.2.2), which may 
require a larger commitment than ADHD patients and their parents are willing to agree to. 
In addition to recruitment difficulties, a complicated treatment intervention could also lead 
to problems with compliance and high subject dropout rates. While the development of a 
computational optimization method to streamline the TVG training schedule could 
ameliorate some of the intervention’s complexity, this treatment intervention will still 
require a greater investment of effort to complete than a pharmacological intervention.  
 To ameliorate potential problems with compliance even further, a parental 
involvement component could be added to the intervention. This component could 
encourage the participation of parents in a supportive coaching role, and include parent 
training to improve the quality of the interactions with their child. The inclusion of 
psychosocial interventions targeting parents is an effective treatment for children with 
ADHD193, and has been found to enhance the effects of working memory training193. 
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Furthermore, positive parental and family interactions have shown protective effects 
against the development of ADHD in cross-sectional and longitudinal studies54-59. Thus, 
modifying the therapeutic video game intervention to increase parental involvement could 
prove to be an effective strategy to increase treatment compliance and efficacy.   
5.6 Conclusion 
An orphan drug indication for a drug/device combination of stimulants with the 
online game Minecraft to train executive function deficits is being pursued for the treatment 
of ADHD-like symptoms in Fragile X Syndrome. This intervention will utilize a novel 
personalized medicine approach where an individualized treatment regimen consisting of 
an initial stimulant dose recommendation and schedule of therapeutic video game activities 
will be determined from the initial ADHD assessment results of new patients. In the model, 
a set of ANNs will first be trained to resemble the pattern of executive function deficits 
reflected in a new patient’s assessment responses. A large set of virtual tasks resembling 
the therapeutic video game activities will be tested in the model, and the set of virtual tasks 
that produces the maximum improvements in the ANNs of the virtual “subject” will predict 
the analogous set of therapeutic video game tasks most beneficial for the human patient. 
The translational efficacy of this computational optimization method to human subjects 
will then be determined in a future clinical study where an experimental group completing 
a computationally optimized executive function activity training schedule is compared to 
a control group that completes a generic, non-optimized executive function activity training 
schedule. This application of ANNs as a guide for optimization of clinical study 
interventions and individualized therapy recommendations is a novel use of computational 
approaches to save time and expense in a clinical development process and improve the 
medical treatment of patients with ADHD.
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